UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE

SECURITIES EXCHANGE ACT OF 1934

Filed by the Registrant  ☒

Filed by a Party other than the Registrant  ☐

Check the appropriate box:

Preliminary Proxy Statement

Confidential, for Use of the Commission Only (as permitted by Rule

14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material under

§240.14a-12

Oaktree Specialty Lending Corporation

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

No fee required.

Fee paid previously with preliminary materials.

Fee computed on table below per Exchange Act Rules

14a-6(i)(1)
and
0-11.



Oaktree Specialty Lending Corporation

333 South Grand Avenue, 28

th
28th Floor

Los Angeles, CA 90071

Dear Stockholders:

You are cordially invited to attend the 2024 SpecialAnnual Meeting of Stockholders (the “Special“Annual Meeting”) of Oaktree Specialty Lending Corporation (the “Company”) to be held virtually on March 4, 2024, at 10:3000 a.m., Pacific Time (1:3000 p.m., Eastern Time) at the following website: www.virtualshareholdermeeting.com/ocsl2024sm.ocsl2024. Stockholders of record at the close of business on January 4,5, 2024 are entitled to notice of, and to vote at, the SpecialAnnual Meeting or any adjournment or postponement thereof. Details of the business to be conducted at the SpecialAnnual Meeting are given in the accompanying Notice of Virtual SpecialAnnual Meeting and proxy statement. The proxy statement is firstand the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2023 are being sentmade available to the Company’s stockholders via the Internet on or about January 10,19, 2024. Your vote is very important to us.

The Board of Directors including all of the independent directors, recommends that you vote “FOR” the proposalelection of each of the nominees proposed by the Board of Directors and described in the accompanying proxy statement.

statement and “FOR” the proposal to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending September 30, 2024. You can vote for the Board of Directors’ nominees and on the other matters to be voted on at the Annual Meeting by following the instructions on the Notice of Internet Availability of Proxy Materials and voting by Internet or telephone.

It is important that your shares be represented at the SpecialAnnual Meeting. Please follow the instructions on the enclosed proxy cardNotice of Internet Availability of Proxy Materials and vote via the Internet by telephone or by signing, dating and returning the enclosed proxy card.telephone. We encourage you to vote via the Internet as it saves us significant time and processing costs.

However, the Notice of Internet Availability of Proxy Materials includes instructions on how to request a hard copy of the proxy statement and proxy card for the Annual Meeting free of charge, and you may vote your proxy by returning your proxy card to us after you request the hard copy materials. Voting by proxy does not deprive you of your right to participate in the SpecialAnnual Meeting.

No matter how many or few shares in the Company you own, your vote and participation are very important to us.

Sincerely,

/s/ Armen Panossian

Armen Panossian

Chief Executive Officer

Important Notice Regarding the Availability of Proxy Materials for the SpecialAnnual Meeting of Stockholders to Be Held on March 4, 2024.

The accompanying proxy statement isand Annual Report on Form 10-K for the year ended September 30, 2023 are also available at https://www.oaktreespecialtylending.com.



Table of Contents

OAKTREE SPECIALTY LENDING CORPORATION

333 South Grand Avenue, 28

th
28th Floor

Los Angeles, CA 90071

NOTICE OF VIRTUAL 2024 SPECIALANNUAL MEETING OF STOCKHOLDERS

Online Meeting Only – No Physical Meeting Location

www.virtualshareholdermeeting.com/ocsl2024sm

ocsl2024

March 4, 2024, 10:3000 a.m., Pacific Time (1:3000 p.m., Eastern Time)

Dear Stockholders:

The 2024 SpecialAnnual Meeting of Stockholders (the “Special“Annual Meeting”) of Oaktree Specialty Lending Corporation, a Delaware corporation (the “Company”), will be conducted online on March 4, 2024, at 10:3000 a.m., Pacific Time (1:3000 p.m., Eastern Time), at the following website: www.virtualshareholdermeeting.com/ocsl2024sm.

ocsl2024.

At the SpecialAnnual Meeting, in addition to transacting such other business as may properly come before the meeting and any adjournments and postponements thereof, the Company’s stockholders will consider and vote on a proposal to authorizethe following proposals:

To elect two directors, who will each serve until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualifies; and

To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company withfor the approval of the Board of Directors, to sell or otherwise issue shares of its common stock at a price below its then current net asset value per share, provided that the number of shares issued does not exceed 25% of its then outstanding common stock.fiscal year ending September 30, 2024.

THE BOARD OF DIRECTORS, INCLUDING ALL OF THE INDEPENDENT DIRECTORS RECOMMENDS THAT YOU VOTE “FOR” THE PROPOSALDIRECTOR NOMINEES DESCRIBED IN THE ACCOMPANYING PROXY STATEMENT.

STATEMENT AND “FOR” THE PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2024.

You have the right to receive notice of, and to vote at, the SpecialAnnual Meeting if you were a stockholder of record of the Company at the close of business on January 4,5, 2024. AThe Company is furnishing a proxy statement is attachedand proxy card to thisits stockholders on the Internet, rather than mailing printed copies of those materials to each of its stockholders. If you received a Notice that describesof Internet Availability of Proxy Materials by mail, you will not receive a printed copy of the matter to be voted upon atproxy statement and proxy card unless you request them. Instead, the Special Meeting or any adjournment(s) or postponement(s) thereof. The enclosed proxy cardNotice of Internet Availability of Proxy Materials will instruct you as to how you may access and review the proxy statement, and vote your proxy, viaon the Internet, by telephone or by signing, dating and returning the enclosed proxy card.

Internet.

Whether or not you plan to participate in the SpecialAnnual Meeting, we encourage you to vote your shares by following the instructions on the enclosed proxy card. Please note, however, that if you wish to vote during the Special Meeting and your shares are heldNotice of record by a broker, bank, trustee or nominee, you must obtain a “legal” proxy issued in your name from that record holder.

Internet Availability of Proxy Materials.

We are not aware of any other business, or any other nominees for election as director of the Company, that may properly be brought before the SpecialAnnual Meeting.

Thank you for your continued support of the Company.

By order of the Board of Directors,

/s/ John B. Frank

John B. Frank

Chairman

Los Angeles, CA

January 10,19, 2024

To ensure proper representation at the SpecialAnnual Meeting, please follow the instructions on the enclosed proxy cardNotice of Internet Availability of Proxy Materials to vote your shares via the Internet byor telephone, or by requesting, signing, dating and returning the encloseda proxy card. Even if you vote your shares prior to the SpecialAnnual Meeting, you still may participate in the SpecialAnnual Meeting.



Table of Contents

TABLE OF CONTENTS

   Page 

1

General

1

Annual Meeting Information

1

Availability of Proxy and Annual Meeting Materials

1

Purpose of Annual Meeting

1

Voting Information

   2 

   2 

   2 

   2 
2
2
2
3
3

   32 

   32 

   3 

   43 

   43 

   43 

   43 

   5 

   67 

8

Directors

8

Executive Officers

9

Biographical Information

10

Board Leadership Structure

13

Board’s Role in Risk Oversight

14

Transactions with Related Persons

   15 

   1517 

   1517 

   1519 
19

Corporate Governance Documents

19

Director Independence

19

Evaluation

20

Communications with Directors

20

Board Meetings and Committees

20

Audit Committee

20

Compensation Committee

20

Nominating and Corporate Governance Committee

21

Co-Investment Committee

22

Code of Business Conduct

22

Securities Trading Policy

22

Executive Compensation

23

Director Compensation

23

PROPOSAL 2 — RATIFY THE APPOINTMENT OF ERNST  & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE 2024 FISCAL YEAR

25

Independent Auditor’s Fees

25

Required Vote

25

Audit Committee Report

26

OTHER MATTERS

28

Stockholder Proposals

28

Other Business

28

Delivery of Proxy Materials

   1628 

   16
1629 

i


1

Table of Contents

Oaktree Specialty Lending Corporation

333 South Grand Avenue, 28

th
28th Floor

Los Angeles, CA 90071

PROXY STATEMENT

Virtual 2024 SpecialAnnual Meeting of Stockholders

General

We are furnishing you this proxy statement in connection with the solicitation of proxies by the Board of Directors (the “Board”) of Oaktree Specialty Lending Corporation (the “Company,” “we,” “us,” or “our”) for use at the Company’s 2024 SpecialAnnual Meeting of Stockholders (the “Special“Annual Meeting”).

This proxy statement is firstand the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2023 are being mailedmade available to the Company’s stockholders via the Internet on or about January 10,19, 2024. This proxy statement summarizesWhen we refer to the information regardingCompany’s fiscal year, we mean the matter to be voted upon at12-month period ending September 30 of the Special Meeting. stated year (for example, fiscal year 2023 was October 1, 2022 through September 30, 2023).

We encourage you to vote your shares by following the instructions on the enclosed proxy cardNotice of Internet Availability of Proxy Materials and granting a proxy (i.e.(i.e., authorizing someone to vote your shares). If you provide voting instructions, either via the Internet, by telephone or by requesting, signing, dating and returning the encloseda proxy card, and the Company receives them in time for the SpecialAnnual Meeting, the persons named as proxies will vote your shares in the manner that you specified.

Special

Annual Meeting Information

The SpecialAnnual Meeting will be a completely virtual meeting. There will be no physical meeting location and the meeting will only be conducted via live webcast. The SpecialAnnual Meeting will be held on March 4, 2024 at 10:3000 a.m., Pacific Time (1:3000 p.m., Eastern Time). To participate in the SpecialAnnual Meeting, visit www.virtualshareholdermeeting.com/ocsl2024smocsl2024 and enter the

16-digit
control number included in your Notice of Internet Availability of Proxy Materials, on the enclosed proxy card you received, or in the instructions that accompanied your proxy materials. Online
check-in
will begin at 10:209:55 a.m., Pacific Time (1:20(12:55 p.m., Eastern Time). Please allow time for online
check-in
procedures.

You are entitled to participate in the SpecialAnnual Meeting only if you are a stockholder of the Company as of the close of business on the record date for the SpecialAnnual Meeting, which is January 4,5, 2024 (the “Record Date”), or you hold a valid proxy for the SpecialAnnual Meeting.

Availability of Proxy and SpecialAnnual Meeting Materials

This proxy statement isand the Company’s Annual Report on Form 10-K for the year ended September 30, 2023 are also available at https://www.oaktreespecialtylending.com.

Purpose of SpecialAnnual Meeting

In addition to transacting such other business as may properly come before the SpecialAnnual Meeting and any adjournments or postponements, at the SpecialAnnual Meeting, the Company’s stockholders will be asked to approve a proposal to authorizevote on the Company, with the approval of the Board, to sell or otherwise issue shares of its common stock at a price below its then current net asset value (“NAV”) per share, provided that the number of shares issued does not exceed 25% of its then outstanding common stock (the “Proposal”).following proposals:

1.

To elect two directors, who will each serve until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualifies; and

2.

To ratify the selection of Ernst & Young LLP (“EY”) to serve as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2024.

1


Voting Information

General

THE BOARD INCLUDING ALL OF THE INDEPENDENT DIRECTORS, RECOMMENDS THAT YOU VOTE “FOR” THE PROPOSAL.

2

DIRECTOR NOMINEES DESCRIBED IN THIS PROXY STATEMENT AND “FOR” THE PROPOSAL TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2024.

Table of Contents

Voting Securities

You may cast one vote for each share of the Company’s common stock that you owned as of the Record Date. Each share of the Company’s common stock has equal voting rights with all other shares of the Company’s common stock, which is the only class of voting securities outstanding of the Company. As of January 4,5, 2024, the Company had 78,965,350 shares of common stock outstanding.

Quorum Required

For the Company to conduct business at the SpecialAnnual Meeting, a quorum of the Company’s stockholders must be present at the SpecialAnnual Meeting. The presence at the SpecialAnnual Meeting, virtually or by proxy, of the holders of a majority of the shares of the Company’s common stock outstanding on the Record Date will constitute a quorum. Abstentions will be treated as shares present for quorum purposes. Shares for which brokers have not received voting instructions from the beneficial owner of the shares and do not have discretionary authority to vote on certain proposals (which are considered “broker

non-votes”
with respect to such proposals) will not be treated as shares present for quorum purposes.

The Chairman of the Company shall have the power to adjourn the SpecialAnnual Meeting, whether or not a quorum is present, from time to time for any reason and without notice other than announcement at the SpecialAnnual Meeting.

Submitting Voting Instructions for Shares Held Through a Broker, Bank, Trustee or Nominee

If you hold shares of the Company’s common stock through a broker, bank, trustee or nominee, you must direct your intermediary regarding how you would like your shares voted by following the voting instructions you receive from your broker, bank, trustee or nominee. If you hold shares of the Company’s common stock through a broker, bank, trustee or nominee and want to participate in the SpecialAnnual Meeting, you must follow the instructions you receive from your broker, bank, trustee or nominee.

Please instruct your broker, bank, trustee or nominee regarding how you would like your shares voted so your vote can be counted.

Discretionary Voting

Brokers, banks, trustees and nominees have discretionary authority to vote on “routine” matters, but not on

“non-routine”
matters. The Proposal“routine” matter being considered at this Annual Meeting is a
the ratification of the appointment of the Company’s independent registered public accounting firm, and the “non-routine”
matter. matter being considered at this Annual Meeting is the election of directors. If you hold your shares in street name (or “nominee name”) and do not provide your broker, bank, trustee or nominee who holds such shares of record with specific instructions regarding how to vote on the proposal to elect a director, your broker may not be permitted to vote your shares on the Proposal.
such “non-routine” proposals.

Please note that to be sure your vote is counted on the Proposal,Company’s proposal to elect directors, you should instruct your broker, bank, trustee or nominee how to vote your shares. If you do not provide voting instructions, votes may not be cast on your behalf with respect to the Proposal.such proposal.

2


Authorizing a Proxy for Shares Held in Your Name

If you are a record holder of shares of the Company’s common stock, you may authorize a proxy to vote on your behalf by following the instructions provided on the enclosed proxy card or in the instructions that accompanied your proxy materials.Notice of Internet Availability of Proxy Materials. Authorizing your proxy will not limit your right to participate in the SpecialAnnual Meeting and vote your shares online. A properly completed and submitted proxy will be voted in accordance with your instructions unless you subsequently revoke your instructions. If you authorize a proxy without indicating your voting instructions, the proxyholder will vote your shares according to the Board’s recommendations. Internet and telephone voting procedures are designed to authenticate the stockholder’s identity and to allow stockholders to vote their shares and confirm that their instructions have been properly recorded. Your Internet or telephone vote authorizes the named proxies to vote your shares in the same manner as if you had marked, signed and returned a proxy card.

3

Table of Contents

Receipt of Multiple Proxy Cards

Some of the Company’s stockholders hold their shares in more than one account and may receive a separate Notice of Virtual Special MeetingInternet Availability of Proxy Materials for each of those accounts. To ensure that all of your shares are represented at the SpecialAnnual Meeting, we recommend that you vote by following the instructions in each Notice of Virtual Special MeetingInternet Availability of Proxy Materials you receive.

Revoking Your Proxy

If you are a stockholder of record of the Company, you can revoke your proxy at any time before it is exercised by: (i) delivering a written revocation notice that is received prior to the SpecialAnnual Meeting to Oaktree Specialty Lending Corporation, 333 South Grand Avenue, 28th Floor, Los Angeles, CA 90071, Attention: Secretary; (ii) submitting a later-dated proxy that we receive before the conclusion of voting at the SpecialAnnual Meeting; or (iii) participating in the SpecialAnnual Meeting and voting online. If you hold shares of the Company’s common stock through a broker, bank, trustee or nominee, you must follow the instructions you receive from them in order to revoke your voting instructions. Participating in the SpecialAnnual Meeting does not revoke your proxy unless you also vote online at the SpecialAnnual Meeting.

Votes Required

Election of directors. The affirmative vote of eacha plurality of the followingshares of the Company’s common stock outstanding and entitled to vote thereon at the Annual Meeting is required to approveelect each director nominee (i.e., the Proposal: (1)candidate receiving the most “for” votes will win each election). Under a plurality vote standard, the nominees that receive the highest number of votes cast in an election will be elected regardless of whether they receive a majority of votes cast. In uncontested elections, such as those described in this proxy statement, this means that a director can be elected with a single “for” vote. Stockholders may not cumulate their votes. Votes to “withhold authority” and broker non-votes will not be included in determining the number of votes cast and, as a result, will have no effect on this proposal.

Ratification of independent registered public accounting firm. The affirmative vote of a majority of the Company’s outstanding voting securities and (2) a majorityvotes cast at the Annual Meeting is required to ratify the appointment of EY to serve as the Company’s independent registered public accounting firm (i.e., the number of shares voted “for” the ratification of the Company’s outstanding voting securities that are not held by affiliated personsappointment of EY exceeds the number of votes “against” the ratification of the Company. For purposesappointment of the Proposal, the Investment Company Act of 1940, as amended (the “1940 Act”), defines a majority of the outstanding voting securities as the vote of the lesser of: (1) 67% or more of the voting securities of the Company present at the Special Meeting, if the holders of more than 50% of the outstanding voting securities of the Company are present or represented by proxyEY). Abstentions and (2) more than 50% of the outstanding voting securities of the Company. The outstanding shares of common stock represent the Company’s outstanding voting securities. Abstentions,broker non-votes, if any, will not be included in determining the number of votes cast and, as a result, will have theno effect of a vote against the Proposal.

on this proposal.

Information Regarding This Solicitation

The Company will bear the expenses of the solicitation of proxies. In addition to mail and

e-mail,
proxies may be solicited personally, via the Internet or by telephone or facsimile, by regular employees of Oaktree Fund

3


Administration, LLC (“Oaktree Administrator”), the Company’s administrator, and its affiliates and/or a paid solicitor. No additional compensation will be paid to such regular employees for such services. The Company intendscurrently does not intend to useengage a paid solicitor in connection with the services of Broadridge Investor Communication Services Inc. (“Broadridge”) to aid inAnnual Meeting. If the distribution and collection of proxies forCompany retains a solicitor, it estimates that it will pay an estimated feeaggregate of approximately $65,000$11,500 plus pass through charges. Broadridgeout-of-pocket expenses for such services and you could contact yoube contacted by telephone on behalf of the Company and urge yoube urged to vote. BroadridgeIf the Company engages a solicitor, you could be contacted by telephone on behalf of the Company and be urged to vote. The solicitor will not attempt to influence how you vote your shares, but will only ask that you take the time to cast a vote. The Company will reimburse brokers and other persons holding the Company’s common stock in their names, or in the names of nominees, for their expenses for forwarding proxy materials to principals and beneficial owners and obtaining their proxies.

4

Table The principal address of ContentsOaktree Administrator is 333 South Grand Avenue, 28th Floor, Los Angeles, CA 90071.

4


SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth, as of January 4,5, 2024, the beneficial ownership information of each current director, including each nominee for director, of the Company, as well as the Company’s executive officers, and the executive officers and directors as a group. There is no person known to the Company to beneficially own 5% or more of the outstanding shares of the Company’s common stock.stock as of January 5, 2024. Percentage of beneficial ownership is based on 78,965,350 shares of the Company’s common stock outstanding as of January 4,5, 2024.

Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission (“SEC”) and includes voting or investment power with respect to the securities. Ownership information for those persons who beneficially own 5% or more of the shares of the Company’s common stock is based upon filings by such persons with the SEC and other information obtained from such persons, if available.

Unless otherwise indicated, the Company believes that each beneficial owner set forth in the table below has sole voting and investment power over the shares beneficially owned by such beneficial owner. The directors are divided into two groups — interested director and independent directors. The interested director is an “interested person” of the Company as defined in Section 2(a)(19) of the Investment Company Act of 1940, Act.as amended (the “Investment Company Act”). The address of all executive officers and directors is c/o Oaktree Specialty Lending Corporation, 333 South Grand Avenue, 28th Floor, Los Angeles, CA 90071.

Name

  
Number of
Shares

of Common
Stock

Owned
Beneficially
   
Percentage
of

Common
Stock


Outstanding
 

Interested Director:

  

John B. Frank

(1)

   54,261    * 

Independent Directors:

    

Phyllis R. Caldwell

   9,166    * 

Deborah Gero

   19,911    * 

Craig Jacobson

   56,757    * 

Bruce Zimmerman

   19,130    * 

Executive Officers:

    

Christopher McKown

   5,655    * 

Ashley Pak

   2,083    —  * 

Armen Panossian

   12,789    * 

Mathew Pendo

   41,698    * 

Matthew Stewart

   10,781    * 

All Executive Officers and Directors as a Group

(2)

  
232,231
 
*
*

*

Represents less than 1%

(1)

Of the 54,261 shares of the Company’s common stock listed as beneficially owned by John B. Frank, (i) 14,887 shares of the Company’s common stock are held directly by Mr. Frank and (ii) 39,374 shares of the Company’s common stock are held by a member of Mr. Frank’s family and he may be deemed to have voting and/or investment power with respect to, but he has no pecuniary interest in, such shares.

(2)

Amount only includes Section 16(a) reporting persons of the Company.

5


5

Table

The following table sets forth, as of ContentsJanuary 5, 2024, the dollar range of our equity securities that is beneficially owned by each of the current directors of the Company.

Name

Dollar
Range
of Equity
Securities
Beneficially
Owned(1)(2)

Interested Director:

John B. Frank

Over $100,000

Independent Directors:

Phyllis R. Caldwell

Over $100,000

Deborah Gero

Over $100,000

Craig Jacobson

Over $100,000

Bruce Zimmerman

Over $100,000

(1)

Beneficial ownership has been determined in accordance with Rule 16a-1(a)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

(2)

The dollar range of equity securities beneficially owned is based on the closing price per share for the Company’s common stock of $20.91 on January 5, 2024 on The Nasdaq Global Select Market (“Nasdaq”). The dollar range of equity securities beneficially owned are: none, $1 – $10,000, $10,001 – $50,000, $50,001 – $100,000, or over $100,000.

In addition, one of our independent directors, Mr. Jacobson, has greater than $100,000 of investments in certain private funds managed by Oaktree Capital Management, L.P. (“Oaktree”) and its affiliates.

6


THE PROPOSAL 1 AUTHORIZATIONELECTION OF THE COMPANY TO SELL OR OTHERWISE ISSUE SHARES OF ITS COMMON STOCK AT A PRICE BELOW ITS THEN CURRENT NET ASSET VALUE PER SHARE SUBJECT TO THE CONDITIONS SET FORTH IN THIS PROPOSAL
DIRECTORS

The Company is a

closed-end
investment company that has elected to be regulated as a business development company (“BDC”) under the 1940 Act. As a BDC,and affairs of the Company is generally prohibited from issuing sharesmanaged under the oversight of its common stock at a price below the then-current NAV per share unless the Company meets certain conditions, including obtaining stockholder approval. As a result, the Company is seeking the approval of its stockholders so that it may, in one or more public or private offerings of its common stock, sell or otherwise issue shares of its common stock at a price below its then current NAV per share, provided that the number of shares issued does not exceed 25% of its then outstanding common stock and subject to the conditions set forth in this Proposal. If this Proposal is approved by the Company’s stockholders, the authorization would be effective for common stock issued during a twelve-month period following such approval. The authorization would include offerings in connection with acquisitions of other companies or investment portfolios.
Board. The Board including allcurrently consists of the directors who have no financial interest in the Proposal and allfive members, of the directors whowhom four are not “interested persons” of the Company, as defined in Section 2(a)(19) of the 1940 Act, has approvedInvestment Company Act. The Board may modify the Proposal asnumber of its members in accordance with the Company’s fourth amended and restated bylaws, except that no decrease in the best interestsnumber of directors shall shorten the term of any incumbent director. Nasdaq requires that the Company maintain a majority of independent directors on the Board and provides that a director of a business development company is considered to be independent if he or she is not an “interested person”, as defined in Section 2(a)(19) of the Investment Company Act. Therefore, under both the Investment Company Act and applicable Nasdaq rules, a majority of the directors of the Board is independent.

Under the Company’s restated certificate of incorporation, as amended and corrected, directors are divided into three classes. At each annual meeting of the Company’s stockholders, the successors to the directors whose terms expire at such meeting will be elected to hold office for a term expiring at the annual meeting of stockholders held in the third year following the year of his or her election and when his or her successor has been duly elected and qualifies or any director’s earlier resignation, removal from office, death or incapacity.

Each of Ms. Gero and Mr. Jacobson has been nominated for re-election to the Board for a three-year term expiring at the 2027 annual meeting of stockholders of the Company.

No person being nominated by the Board as a director is being proposed for election pursuant to any agreement or understanding between any such person and the Company.

Any stockholder of the Company can vote for or withhold authority on each director nominee. Votes to “withhold authority” and broker non-votes will not be included in determining the number of votes cast and, as a result, will have no effect on the election of any director nominee. In the absence of instructions to the contrary, it is the intention of the persons named as proxies to vote such proxy “FOR” the election of each of the nominees named above. If a nominee should decline or be unable to serve as a director, it is intended that the proxy will be voted for the election of such person nominated by the Board as a replacement. The Board does not have any reason to believe that any director nominee named will be unable or unwilling to serve.

The Board recommends a vote “FOR” the director nominees described in this proxy statement.

7


Director and Executive Officer Information

Directors

Information regarding the Company’s nominees for election as a director at the Annual Meeting and the Company’s continuing directors is set forth below. We have divided the directors into two groups — independent directors and interested directors. The interested director is an “interested person” of the Company, as defined in Section 2(a)(19) of the Investment Company Act.

Name, Address, and
Age(1)

Length of Time
Served; Term of
Office

Principal
Occupation(s)
During the Past
Five
Years

Number of
Portfolios
in the Fund
Complex(2)
Overseen
by the
Director or
Nominee
for Director

Other Directorships Held by
Director or Nominee for
Director During the Past
Five Years(3)

Interested Director

John B. Frank (67)

Director since 2017;
term expires in 2026
Oaktree’s Vice Chairman since 2014.1Member of the board of directors of Oaktree Capital Group, LLC (“OCG”) since 2007; and Chevron Corporation since October 2017. Previously a member of the board of directors of Oaktree Acquisition Corp., Oaktree Acquisition Corp. II, Oaktree Acquisition Corp. III and Oaktree Strategic Income Corporation (“OCSI”)

Independent Directors

Phyllis R. Caldwell (64)

Director since 2021; term expires in 2025Founder and Managing Member of Wroxton Civic Ventures since 2012.1Member of the board of directors of Ocwen Financial Corporation since January 2015; JBG Smith Properties since March 2021; and OneMain Holdings, Inc. since July 2021. Previously a member of the board of directors of Revolution Acceleration Acquisition Corp.

Deborah Gero (63)*

Director since 2019;
term expires, if elected in 2027
Director and Secretary of The Friends of the Brentwood Art Center since September 2016. Ms. Gero also held various positions with American International Group, Inc. and its affiliates (collectively, “AIG”) from 2009 to 2018.2Member of the board of directors of Resolution Re Ltd. since November 2023; United Educators since April 2020; United Way of Greater Los Angeles since November 2020; Newport Re, Ltd. since May 2019; and The Friends of the Brentwood Art Center since September 2016. Member of the board of trustees of Oaktree Strategic Credit Fund (“OSCF”) since 2021. Previously a member of the board of directors of OCSI and Oaktree Strategic Income II, Inc (“OSI2”).

8


Name, Address, and
Age(1)

Length of Time
Served; Term of
Office

Principal
Occupation(s)
During the Past Five
Years

Number of
Portfolios
in the Fund
Complex(2)
Overseen
by the
Director or
Nominee
for Director

Other Directorships Held by
Director or Nominee for
Director During the Past
Five Years(3)

Craig Jacobson (71)*

Director since 2017; term expires, if elected, in 2027Partner of the law firm of Hansen, Jacobson, Teller, Hoberman, Newman, Warran, Richman, Rush, Kaller, Gellman, Meigs & Fox LLP since 1987; Founder at Whisper Advisors LLC since 2015; Founder at New Form Digital from 2014 to January 2019.1Member of the board of directors of Expedia and Charter Communications. Previously a member of the board of directors of Tribune Entertainment and OCSI.

Bruce Zimmerman (66)

Director since 2017; term expires in 2026Senior Advisor of Dalio Family Office (“Dalio”) since September 2023. Chief Investment Officer of Dalio from July 2019 – September 2023.1Member of the board of directors of Advanced Merger Partners, Inc., since February 2021. Previously Vice Chairman of the Board of Trustees for the CommonFund; previously a member of the boards of directors of Vistra Energy Corp. and OCSI.

*

Director nominee.

(1)

The address of all directors is c/o Oaktree Specialty Lending Corporation, 333 South Grand Avenue, 28th Floor, Los Angeles, CA 90071.

(2)

“Fund Complex” includes the Company, Oaktree Gardens OLP, LLC (“OLPG”) and OSCF. Each of OLPG and OSCF is a company that has elected to be regulated as a business development company under the Investment Company Act and has the same investment adviser, Oaktree Fund Advisors, LLC (the “Adviser”), and administrator, Oaktree Administrator, as the Company.

(3)

Except as set forth in this table, no current director of the Company otherwise serves, or has served during the past five years, as a director of an investment company registered under the Investment Company Act or of a company with a class of securities registered pursuant to Section 12 of the Exchange Act or subject to the requirements of Section 15(d) of the Exchange Act.

Executive Officers

The following persons serve in the following capacities for the Company:

Name

Age

Position

Armen Panossian

47Chief Executive Officer and Chief Investment Officer

Mathew Pendo

60President

Matthew Stewart

39Chief Operating Officer

Christopher McKown

42Chief Financial Officer and Treasurer

Ashley Pak

45Chief Compliance Officer

9


Biographical Information

Additional biographical information regarding the Company’s current directors, nominees for director and officers is set forth below.

Interested Director

John B. Frank. Mr. Frank has been a member of the Board since October 2017 and currently serves as a member of the Co-Investment Committee. Mr. Frank has been Oaktree’s Vice Chairman since 2014 and has served on the board of directors of OCG since 2007. Prior to holding this position, Mr. Frank served as Oaktree’s Managing Principal from 2006 to 2014 and served as Oaktree’s General Counsel from 2001 to 2006. As Managing Principal of Oaktree, Mr. Frank was the firm’s principal executive officer and was responsible for all aspects of the firm’s management. Prior to joining Oaktree, Mr. Frank was a partner of the law firm Munger, Tolles & Olson LLP, where he managed a number of notable mergers and acquisitions transactions. While at that firm, he served as primary outside counsel to public and privately-held corporations and as special counsel to various boards of directors and special board committees. Prior to joining Munger, Tolles & Olson LLP in 1984, Mr. Frank served as a law clerk to the Honorable Frank M. Coffin of the United States Court of Appeals for the First Circuit. He is a member of the State Bar of California and, while in private practice, was listed in Woodward & White’s Best Lawyers in America. Mr. Frank is a member of the Board of Directors of Chevron Corporation, ADRx, Inc. and Urban 626 LLC and a Trustee of Wesleyan University, the XPRIZE Foundation and The James Irvine Foundation. Mr. Frank previously served on the Board of Directors of OCSI, Oaktree Acquisition Corp., Oaktree Acquisition Corp. II, and Oaktree Acquisition Corp. III. Mr. Frank holds a B.A. with honors from Wesleyan University and a J.D. magna cum laude from the University of Michigan Law School where he was Managing Editor of the Michigan Law Review and a member of the Order of the Coif.

Mr. Frank’s position as Oaktree’s Vice Chairman and member of the board of directors of OCG and prior positions as Oaktree’s Managing Principal and General Counsel gives him deep knowledge of Oaktree’s operations, capabilities and business relationships. Mr. Frank’s experience as counsel to board of directors and special board committees brings valuable legal insight to the Board. The foregoing qualifications led to the conclusion of the Board that Mr. Frank should serve as a member of the Board.

Independent Directors

Phyllis R. Caldwell. Ms. Caldwell has been a member of the Board since December 2021 and currently serves as chair of the Nominating and Corporate Governance Committee and a member of each of our other Board committees. Ms. Caldwell is founder and has served since 2012 as the managing member of Wroxton Civic Ventures, which provides advisory services on various financial, housing and economic development matters. Previously, Ms. Caldwell was Chief Homeownership Preservation Officer at the U.S. Department of the Treasury, responsible for oversight of the U.S. housing market stabilization, economic recovery and foreclosure prevention initiatives established through the Troubled Asset Relief Program (“TARP”) of the U.S. Department of the Treasury. In addition, Ms. Caldwell held various leadership roles during 11 years at Bank of America, including serving as President of Community Development Banking. Ms. Caldwell has served as a director of Ocwen Financial Corporation since January 2015 and served as the Chair of the Board of Directors of the company from March 2016 until January 2023. In June 2021, Ms. Caldwell became a member of the board of directors of OneMain Holdings, Inc., the country’s largest nonprime installment lender. In March 2021, Ms. Caldwell was appointed as a member of the board of trustees of JBG SMITH Properties, an owner and developer of mixed-use properties in the Washington, D.C. market. From December 2020 to July 2021, Ms. Caldwell served as a member of the board of directors of Revolution Acceleration Acquisition Corp., a special purpose acquisition company, and from January 2014 through September 2018, she served as an independent director of American Capital Senior Floating, Ltd., a business development company. Ms. Caldwell also serves or has served on the boards of other public and private businesses and numerous non-profit organizations engaged in housing and community development finance. Ms. Caldwell received her Master of Business Administration from the Robert H. Smith School of Business at the University of Maryland, College Park and holds a Bachelor of Arts in Sociology, also from the University of Maryland.

10


Through her experiences in government, management and board service, including with American Capital Senior Floating, Ltd., Ms. Caldwell brings extensive knowledge of economic and financial matters. The foregoing qualifications led to the conclusion of the Board that Ms. Caldwell should serve as a member of the Board.

Deborah Gero. Ms. Gero has been a member of the Board since March 2019 and currently serves as chair of the Audit Committee and a member of each of our other Board committees. Ms. Gero has also been a member of the board of trustees of OSCF since December 2021. Ms. Gero has held various positions with AIG, including as a Senior Managing Director and Deputy Chief Investment Officer of AIG Asset Management, where she was responsible for developing the firm’s investment strategy for approximately $300 billion of insurance company portfolios from 2012 to 2018. She joined AIG in 2009 and served as Chief Risk Officer for the Life and Retirement division until 2012. Before joining AIG, Ms. Gero was a consultant from 2003 to 2009, focusing on collateralized debt obligation investment management and investments in insurance companies. Prior to her work as a consultant, Ms. Gero spent eight years at AIG and its stockholderspredecessor entities in a variety of capacities including Portfolio Manager of a $3 billion collateralized debt obligation portfolio and recommends itCorporate Actuary. Previous experiences include numerous actuarial and asset/liability management roles at Conseco, Inc., Tillinghast/Towers-Perrin and Pacific Mutual Life Insurance Company. Ms. Gero currently serves as a director of Resolution Re, Ltd., Newport Re, Ltd. and The Friends of the Brentwood Art Center and as a member of the Investment Committee of United Way of Greater Los Angeles. Ms. Gero has previously served as a director of OCSI, OSI2, Aurora National Life Insurance Company and New California Life Holdings, as well as several insurance and asset management subsidiaries of AIG. Ms. Gero received a B.A. degree in mathematics from the University of Notre Dame. She is a CFA charterholder, a fellow in the Society of Actuaries and a member of the American Academy of Actuaries.

Through her experience in insurance and financial services, Ms. Gero brings extensive experience in risk management, strategic planning and mergers and acquisitions to the stockholdersBoard. Due to such experience and Ms. Gero’s knowledge of and experience in finance and accounting, the Board determined that Ms. Gero is an “audit committee financial expert” as defined under SEC rules. Ms. Gero’s many experiences also make her skilled in leading committees requiring substantive expertise, including serving as the chair of the audit committee of the Board. The foregoing qualifications led to the conclusion of the Board that Mr. Gero should serve as a member of the Board.

Craig Jacobson. Mr. Jacobson has been a member of the Board since October 2017 and currently serves as chair of the Compensation Committee and a member of each of our other Board committees. Mr. Jacobson is a founder and partner with the law firm of Hansen, Jacobson, Teller, Hoberman, Newman, Warran, Richman, Rush, Kaller, Gellman, Meigs & Fox LLP where he practices in the area of media business. Mr. Jacobson founded New Form Digital, a venture with Discovery Media and ITV Studios which produces scripted short form online content, which he operated from 2014 to January 2019. In addition, Mr. Jacobson founded and operates Whisper Advisors, a boutique investment banking and advisory company. Mr. Jacobson serves on the Board of Directors of Expedia and Charter Communications. He chairs the Nominating Committee and is a member of the Audit and Compensation Committees of Expedia and is a member of the Nominating Committee of Charter Communications. Mr. Jacobson has previously served as a director of OCSI, Tribune Media Company, TicketMaster, Eventful and Aver Media. Mr. Jacobson received a J.D. from the George Washington University Law School and holds a B.A. from Brown University.

Through his membership of the Board of Directors of several companies, Mr. Jacobson brings extensive experience as the director of both private and public companies to the Board. Mr. Jacobson’s services on the Audit and Compensation Committees of Expedia and Tribune Entertainment provides Mr. Jacobson with the knowledge and skills to significantly contribute to the committees of the Board. The foregoing qualifications led to the conclusion of the Board that Mr. Jacobson should serve as a member of the Board.

Bruce Zimmerman. Mr. Zimmerman has been a member of the Board since October 2017 and currently serves as our lead independent director, the chair of the Co-Investment Committee and a member of each of our other Board committees. Mr. Zimmerman has served as Senior Advisor of Dalio Family Office since September 2023, where he previously served as Chief Investment Officer from July 2019 to September 2023, and was the Chief Executive Officer and Chief Investment Officer of the University of Texas Investment Management Company (“UTIMCO”) from 2007 until 2016. UTIMCO is the second largest investor of discretionary university

11


assets worldwide. Before joining UTIMCO, Mr. Zimmerman was Chief Investment Officer and Global Head of Pension Investments at Citigroup. Mr. Zimmerman also served as Chief Financial Officer and Chief Administrative Officer of Citigroup Alternate Investments, which invests proprietary and client capital across a range of hedge fund, private equity, real estate and structured credit vehicles. Prior to his work at Citigroup, Mr. Zimmerman spent thirteen years at Texas Commerce Bank/JP Morgan Chase in a variety of capacities including Merger & Acquisition Investment Banking, Internet and ATM Retail Management, Consumer Marketing and Financial Planning, Strategy and Corporate Department. Mr. Zimmerman previously served as a director of OCSI, Vistra Energy Corp., an integrated power company, as Vice Chairman of the Board of Trustees for the CommonFund, a nonprofit asset management firm and on the Investment Committee for the Houston Endowment. Mr. Zimmerman was previously the International President of the B’nai B’rith Youth Organization. Mr. Zimmerman received an MBA from Harvard Business School and graduated Magna Cum Laude from Duke University.

Mr. Zimmerman’s executive experience brings extensive business, investment and management expertise to his Board service. His previous positions as Chief Financial Officer and Chief Accounting Officer bring valuable financial oversight skills to the Board. The foregoing qualifications led to the conclusion of the Board that Mr. Zimmerman should serve as a member of the Board.

Executive Officers

Armen Panossian. Mr. Panossian has served as Chief Executive Officer and Chief Investment Officer for the Company since September 2019. Mr. Panossian has served as the Chairman, Chief Executive Officer and Chief Investment Officer of OSCF and OLPG since December 2021 and February 2023, respectively. Mr. Panossian also served as Chief Executive Officer and Chief Investment Officer of OCSI and OSI2 from September 2019 to March 2021 and from September 2019 to January 2023, respectively. Mr. Panossian is a managing director and Oaktree’s Head of Performing Credit where his responsibilities include oversight of the firm’s performing credit activities including the senior loan, high yield bond, private credit, convertibles, structured credit and emerging markets debt strategies. He also serves as a portfolio manager within the Global Private Debt and Global Credit strategies. Mr. Panossian joined Oaktree’s in 2007 as a senior member of its Global Opportunities group. In January 2014, he joined the U.S. Senior Loan team to assume co-portfolio management responsibilities and lead the development of Oaktree’s CLO business. Mr. Panossian joined Oaktree from Pequot Capital Management, where he worked on their approval. For these purposes,distressed debt strategy. Mr. Panossian received a B.A. degree in economics with honors and distinction from Stanford University, where he was elected to Phi Beta Kappa. Mr. Panossian then went on to receive an M.S. degree in health services research from Stanford Medical School and J.D. and M.B.A. degrees from Harvard Law School and Harvard Business School. Mr. Panossian serves on the Advisory Board of the Stanford Institute for Economic Policy Research. He is a member of the State Bar of California.

Mathew Pendo. Mr. Pendo has served as President of the Company since August 2019. Mr. Pendo has served as President of OSCF and OLPG since December 2021 and February 2023, respectively. Mr. Pendo also currently serves as Managing Director, Head of Corporate Development and Capital Markets for Oaktree, which he joined in 2015. Mr. Pendo previously served as Chief Operating Officer of the Company from October 2017 to January 2022, as Chief Operating Officer and President of OCSI from October 2017 and August 2019, respectively, until March 2021, as Chief Operating Officer of OSI2 from July 2018 until December 2021, as President of OSI2 from August 2019 until January 2023 and as Chief Operating Officer of Oaktree Acquisition Corp. II. from August 2020 until June 2022.

Prior to joining Oaktree in 2015, Mr. Pendo was at the investment banking boutique of Sandler O’Neill Partners, where he was a managing director focused on the financial services industry. Prior thereto, Mr. Pendo was the chief investment officer of TARP, where he was honored with the Distinguished Service Award. There, he built and managed a team of 20 professionals overseeing the Treasury’s $200 billion TARP investment activities across multiple industries including AIG, GM and the banks, and all levels of the capital structure.

12


Mr. Pendo began his career at Merrill Lynch, where he spent 18 years, starting in their investment banking division before becoming managing director of the technology industry group. Subsequently, Mr. Pendo was a managing director at Barclays Capital, first serving as co-head of U.S. Investment Banking and then co-head of Global Industrials group. Mr. Pendo currently serves as a member of the Board of directors are not deemedof 17 Capital and previously served as a member of the Board of Directors of Keypath Education, Inc., New IPT Holdings, LLC and SuperValu Inc. He received a bachelor’s degree in economics from Princeton University, cum laude.

Matthew Stewart. Mr. Stewart has served as Chief Operating Officer of the Company since January 2022. Mr. Stewart has served as Chief Operating Officer of OSCF and OLPG since December 2021 and February 2023, respectively. Mr. Stewart is a Managing Director and investment professional on Oaktree’s Strategic Credit team. Prior to havejoining Oaktree in 2017, Mr. Stewart was a financial interest solely by reasonvice president at Fifth Street Management. Prior thereto, he was a director at Stifel Nicolaus where he worked in the Leveraged Finance Group. Mr. Stewart began his career as a senior associate at BDO Consulting in the Business Restructuring group before moving on to serving as a vice president in the institutional fixed income business at Knight Capital Group. Mr. Stewart previously served as the Chief Operating Officer of their ownershipOSI2 from December 2021 until January 2023. He received a B.B.A. in finance and a B.S. in accountancy from Villanova University. Mr. Stewart is a Certified Public Accountant (inactive) and CFA charterholder.

Christopher McKown. Mr. McKown has served as Chief Financial Officer and Treasurer of the Company since November 2021. Mr. McKown has served as Chief Financial Officer and Treasurer of OSCF and OLPG since December 2021 and February 2023, respectively. Mr. McKown joined Oaktree in 2011 and currently serves as a Managing Director responsible for fund accounting and reporting for Oaktree’s Strategic Credit strategy. Mr. McKown previously served as the Chief Financial Officer and Treasurer of OSI2 from January 2022 until January 2023, Assistant Treasurer of OSI2 and the Company from July 2018 until January 2022 and October 2017 until November 2021, respectively and also served as Assistant Treasurer of OCSI from October 2017 until March 2021. Prior to joining Oaktree, Mr. McKown worked in the audit practice at KPMG LLP. Mr. McKown received a B.A. degree in business economics with a minor in accounting cum laude from the University of California, Los Angeles and is a Certified Public Accountant (inactive).

Ashley Pak. Ms. Pak has served as the Chief Compliance Officer of the Company since November 2021. Ms. Pak has served as Chief Compliance Officer of OSCF and OLPG since December 2021 and February 2023, respectively. She previously served as Chief Compliance Officer of OSI2 from November 2021 to January 2023. Ms. Pak joined Oaktree in 2007 and currently serves as a Managing Director in the Compliance Department. Prior to joining Oaktree, she was a Compliance/Legal Specialist at Associated Securities Corp. Ms. Pak received a B.A. in Business Administration from Seattle University and an MBA from the University of Massachusetts, Amherst – Isenberg School of Management.

Board Leadership Structure

The Board monitors and performs oversight roles with respect to the Company’s business and affairs, including with respect to investment practices and performance, compliance with regulatory requirements and the services, expenses and performance of service providers. Among other things, the Board approves the appointment of the Company’s common stock.investment adviser and officers, reviews and monitors the services and activities performed by the Company’s investment adviser and officers and approves the engagement of, and reviews the performance of, the independent registered public accounting firm.

Under the Company’s fourth amended and restated bylaws, the Board may designate a chairman to preside over the meetings of the Board and meetings of stockholders and to perform such other duties as may be assigned to him or her by the Board. The Company does not have a fixed policy as to whether the chairman of the Board should be an independent director; the Company believes that havingit should maintain the flexibility to sell or otherwise issue common stock belowselect the chairman and reorganize its then current NAV per share in certain instancesleadership structure, from time to time, based on the criteria that is in the Company’s best interests and the best interests of its stockholders. This would,the Company’s stockholders at such times. The Board has established

13


corporate governance procedures to guard against, among other things, provide accessan improperly constituted Board. Pursuant to the capital markets to take advantageCompany’s Corporate Governance Policy, whenever the chairman of attractive investment and acquisition opportunities during periods of market dislocation or volatility and to add financial flexibility to comply with regulatory requirements and debt facility covenants, including any applicable asset coverage ratios. In addition, the Board noted that certain ratings agencies view stockholder authorization to issue sharesis not an independent director, the chairman of common stock below its then current NAV per share favorably. Upon obtaining the requisite stockholder approval,Company’s Nominating and Corporate Governance Committee or, if there has been appointed a lead independent director, the lead independent director will act as the presiding independent director at meetings of the “Non-Management Directors” (which will include the independent directors and other directors who are not officers of the Company will complyeven though they may have another relationship with the conditions described in this proxy statement in connection with any issuance undertaken pursuant to such authorization. A discussionCompany or its management that prevents them from being independent directors). Currently, Mr. Zimmerman serves as the designated lead independent director of the risksBoard.

Presently, Mr. Frank serves as the Chairman of dilution appears below.

Backgroundthe Board. Mr. Frank’s familiarity with Oaktree’s investment platform and Reasonsextensive knowledge of the financial services industry qualify him to Offer Common Stock Below NAV
Market Conditions Have Created, and May inserve as the Future Create, Attractive Investment and Acquisition Opportunities
From time to time, global capital markets may experience periods of disruption and instability. For example, rising interest rates, geopolitical conflicts and concerns regarding a U.S. and global recession are currently causing overall economic and financial market instability both globally and in the United States.Chairman. The Company believes that favorableit is best served through this existing leadership structure, as Mr. Frank’s relationship with Oaktree provides an effective bridge and encourages an open dialogue between Oaktree and the Board.

The Company’s corporate governance practices include regular meetings of its independent directors in executive session without the presence of interested directors and management, the establishment of an Audit Committee, Nominating and Corporate Governance Committee and Compensation Committee comprised solely of independent directors and the appointment of a chief compliance officer, with whom the independent directors of the Company meet with in executive session at least once a year, for administering the Company’s compliance policies and procedures. While certain non-management members of the Board may participate on the boards of directors of other public companies, the Company monitors such participation to ensure it is not excessive and does not interfere with their duties to the Company.

Board’s Role in Risk Oversight

The Board performs its risk oversight function primarily through (i) four standing committees, which report to the Board and, with the exception of the Co-Investment Committee, are comprised solely of independent directors, and (ii) active monitoring by the Company’s chief compliance officer and its compliance policies and procedures.

As described below in more detail, the Audit Committee, the Compensation Committee, the Nominating and Corporate Governance Committee and the Co-Investment Committee assist the Board in fulfilling its risk oversight responsibilities. The Audit Committee’s risk oversight responsibilities include overseeing the Company’s accounting and financial reporting processes, systems of internal controls regarding finance and accounting, and audits of the Company’s financial statements, as well as the establishment of guidelines and making recommendations to the Board regarding the valuation of the Company’s loans and investments. The Compensation Committee’s risk oversight responsibilities include reviewing and approving the reimbursement by the Company of the compensation of its chief financial officer and chief compliance officer and their staffs and other non-investment professionals at Oaktree that perform duties for the Company. The Nominating and Corporate Governance Committee’s risk oversight responsibilities include selecting, researching and nominating directors for election by the Company’s stockholders, developing and recommending to the Board a set of corporate governance principles and overseeing the evaluation of the Board and management. The Co-Investment Committee’s risk oversight responsibilities include reviewing and approving certain co-investment transactions in accordance with the conditions of the exemptive order the Company has received from the SEC.

The Board also performs its risk oversight responsibilities with the assistance of the Company’s chief compliance officer. The Board annually reviews a written report from the Company’s chief compliance officer discussing the adequacy and effectiveness of the Company’s compliance policies and procedures. The chief compliance officer’s annual report addresses: (i) the operation of the compliance policies and procedures of the Company, its investment adviser and certain other entities since the last report; (ii) any material changes to such

14


policies and procedures since the last report; (iii) any recommendations for material changes to such policies and procedures as a result of the chief compliance officer’s annual review; and (iv) any compliance matter that has occurred since the date of the last report about which the Board would reasonably need to know to oversee compliance. In addition, the Company’s chief compliance officer meets in executive session with the Board’s independent directors at least once a year.

The Company believes that the role of the Board in risk oversight is effective and appropriate given the extensive regulation to which it is already subject as a business development company. As a business development company, the Company is required to comply with certain regulatory requirements that control the levels of risk in its businesses and operations.

Transactions with Related Persons

Investment Advisory Agreement

The Company is externally managed by the Adviser, an affiliate of Oaktree, pursuant to an investment advisory agreement (as amended and restated from time to time, the “Investment Advisory Agreement”). Mr. Frank, an interested member of the Board, has a direct or indirect pecuniary interest in the Adviser. The Adviser is a registered investment adviser under the Investment Advisers Act of 1940, as amended, that is partially and indirectly owned by OCG. In 2019, Brookfield Asset Management Inc., which we refer to as “Brookfield,” acquired a majority economic interest in OCG. OCG operates as an independent business within Brookfield, with its own product offerings and investment, marketing and support teams.

Under the Investment Advisory Agreement, fees payable to the Adviser equal (a) a base management fee and (b) an incentive fee based on the Company’s performance. The base management fee is calculated at an annual rate of 1.50% of the value of the Company’s total gross assets, including any investment made with borrowings, but excluding cash and cash equivalents; provided, however, that the base management fee on the Company’s gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents, that exceed the product of (A) 200% (as calculated in accordance with the Investment Company Act and giving effect to exemptive relief the Company received from the SEC with respect to debentures issued by a small business investment company subsidiary) and (B) the Company’s net asset value is 1.00%. In connection with the merger of OCSI with and into the Company on March 19, 2021 (the “ OCSI Merger”), the Company and the Adviser entered into an amended and restated investment advisory agreement, which among other items, waived an aggregate of $6 million of base management fees otherwise payable to the Adviser in the two years following the closing of the OCSI Merger at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter). In connection with the merger of OSI2 with and into the Company on January 23, 2023 (the “OSI2 Merger”), the Adviser waived an aggregate of $9.0 million of base management fees payable to Oaktree as follows: $6.0 million at a rate of $1.5 million per quarter (with such amount appropriately prorated for any partial quarter) in the first year following closing of the OSI2 Merger on January 23, 2023 and $3.0 million at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter) in the second year following closing of the OSI2 Merger.

The incentive fee consists of two parts. The first part is calculated and payable quarterly in arrears and equals 17.5% of the Company’s “pre-incentive fee net investment income” for the immediately preceding quarter, subject to a preferred return, or “hurdle,” and a “catch up” feature. For purposes of the Investment Advisory Agreement, “pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies, other than fees for providing managerial assistance) accrued during the fiscal quarter, minus operating expenses for the quarter (including the base management fee, expenses payable under the Company’s Administration Agreement (as defined below) and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred

15


interest feature (such as original issue discount debt instruments with payment-in-kind interest and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. In addition, pre-incentive fee net investment income does not include any amortization or accretion of any purchase premium or purchase discount to interest income resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger and the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in pre-incentive fee net investment income.

The second part is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Investment Advisory Agreement) and equals 17.5% of the Company’s realized capital gains, if any, on a cumulative basis from the beginning of the fiscal year ending September 30, 2019 through the end of each fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees. The calculation of realized capital gains, realized capital losses and unrealized capital depreciation does (1) not include any such amounts resulting solely from merger-related accounting adjustments in connection with the assets acquired in the OCSI Merger, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in the capital gains incentive fee, (2) include any such amounts associated with the investments acquired in the OCSI Merger for the period from October 1, 2018 to the date of closing of the OCSI Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee and (3) include any such amounts associated with the investments acquired in the OSI2 Merger for the period from August 6, 2018 to the date of closing of the OSI2 Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee.

The Investment Advisory Agreement may be terminated without penalty, upon 60 days’ written notice, by the vote of a majority of the outstanding voting securities of the Company or by the vote of the Company’s directors or by Oaktree.

Administration Agreement

The Company has entered into an administration agreement with Oaktree Administrator (the “Administration Agreement”), which is a wholly-owned subsidiary of Oaktree. Pursuant to the Administration Agreement, Oaktree Administrator provides administrative services necessary for the operations of the Company, which include providing to the Company office facilities, equipment and clerical, bookkeeping and record keeping services at such facilities and such other services as Oaktree Administrator, subject to review by the Board, shall from time to time deem to be necessary or useful to perform its obligations under the Administration Agreement. Oaktree Administrator also provides to the Company portfolio collection functions for interest income, fees and warrants and is responsible for the financial and other records that the Company is required to maintain and prepares, prints and disseminates reports to the Company’s stockholders and reports and all other materials filed with the SEC. In addition, Oaktree Administrator assists the Company in determining and publishing the Company’s net asset value, overseeing the preparation and filing of the Company’s tax returns, and generally overseeing the payment of the Company’s expenses and the performance of administrative and professional services rendered to the Company by others. Oaktree Administrator may also offer to provide, on the Company’s behalf, managerial assistance to the Company’s portfolio companies.

For providing these services, facilities and personnel, the Company reimburses Oaktree Administrator the allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration Agreement, including the Company’s allocable portion of the rent of its principal executive offices (which are located in a building owned by a Brookfield affiliate) at market rates and the Company’s allocable portion of the costs of compensation and related expenses of its chief financial officer and

16


chief compliance officer and their respective staffs and other non-investment professionals at Oaktree that perform duties for the Company. Such reimbursement is at cost, with no profit to, or markup by, Oaktree Administrator. The Administration Agreement may be terminated without penalty, upon 60 days’ written notice, by the vote of a majority of the outstanding voting securities of the Company or by the vote of the Company’s directors or by Oaktree Administrator. For the fiscal year ended September 30, 2023, the Company incurred approximately $1.5 million of administration fees under the Administration Agreement.

Review, Approval or Ratification of Transactions with Related Persons

The independent directors of the Company are required to review, approve or ratify any transactions with related persons (as such term is defined in Item 404 of Regulation S-K).

Material Conflicts of Interest

The Company’s executive officers and directors, and certain members of the Adviser, serve or may serve as officers, directors or principals of entities that operate in the same or a related line of business as the Company does or of investment funds managed by our affiliates. For example, the Adviser presently serves as the investment adviser to OLPG, a private business development company, and OSCF, a continuously offered business development company. All of the Company’s executive officers serve in substantially similar capacities for OLPG and OSCF, and one of the Company’s independent directors serves as an independent director of OSCF. OLPG and OSCF invest in senior secured loans, including first lien, unitranche and second lien debt instruments that pay interest at rates which are determined periodically on the basis of a floating base lending rate, made to private middle-market companies whose debt is rated below investment grade, similar to those the Company targets for investment. Oaktree and its affiliates also manage or sub-advise other business development companies, registered investment companies and private investment funds and accounts, and may manage other such funds and accounts in the future, which have investment mandates that are similar, in whole and in part, with the Company’s. Therefore, there may be certain investment opportunities that satisfy the investment criteria for OLPG, OSCF and the Company as well as other business development companies, registered investment companies and private investment funds and accounts advised or sub-advised by Oaktree or its affiliates. In addition, Oaktree and its affiliates may have obligations to investors in other entities that they advise or sub-advise, the fulfillment of which might not be in the best interests of us or our stockholders.

For example, the personnel of the Adviser may face conflicts of interest in the allocation of investment opportunities to the Company and such other funds and accounts. Oaktree has investment allocation guidelines that govern the allocation of investment opportunities among the investment funds and accounts managed or sub-advised by Oaktree and its affiliates. To the extent an investment opportunity is appropriate for OLPG, OSCF or the Company, or any other investment fund or account managed or sub-advised by Oaktree or its affiliates, Oaktree will adhere to its investment allocation guidelines in order to determine a fair and equitable allocation.

The Company may invest alongside funds and accounts managed or sub-advised by the Adviser and its affiliates in certain circumstances where doing so is consistent with applicable law and SEC staff interpretations. For example, the Company may invest alongside such accounts consistent with guidance promulgated by the staff of the SEC permitting the Company and such other accounts to purchase interests in a single class of privately placed securities so long as certain conditions are met, including that the Adviser, acting on the Company’s behalf and on behalf of other clients, negotiates no term other than price or terms related to price.

In addition, affiliates of the Adviser have received exemptive relief from the SEC to allow certain managed funds and accounts, each of whose investment adviser is Oaktree or an investment adviser controlling, controlled by or under common control with Oaktree, such as the Adviser, as well as proprietary accounts (subject to certain conditions) to participate in negotiated co-investment transactions where doing so is consistent with the applicable registered fund’s or business development company’s investment objective and strategies as well as

17


regulatory requirements and other pertinent factors, and pursuant to the conditions of the exemptive relief. Each potential co-investment opportunity that falls under the terms of the exemptive relief and is appropriate for the Company and any affiliated fund or account, and satisfies the then-current board-established criteria, will be offered to the Company and such other eligible funds and accounts. If there is a sufficient amount of securities to satisfy all participants, the securities will be allocated among the participants in accordance with their proposed order size and if there is an insufficient amount of securities to satisfy all participants, the securities will be allocated pro rata based on the investment proposed by the applicable investment adviser to such participant, up to the amount proposed to be invested by each, which is reviewed and approved by an independent committee of legal, compliance and accounting professionals at attractive risk-adjusted returnsthe Adviser. The Company may also invest alongside funds managed by the Adviser and its affiliates in certain circumstances where doing so is consistent with applicable law and SEC staff interpretations. For example, the Company may invest alongside such accounts consistent with guidance promulgated by the staff of the SEC permitting us and such other accounts to purchase interests in a single class of privately placed securities so long as certain conditions are met, including that the Adviser, acting on our behalf and on behalf of other clients, negotiates no term other than price.

Although Oaktree will endeavor to allocate investment opportunities in a fair and equitable manner, the Company and its common stockholders could be adversely affected to the extent investment opportunities are allocated among the Company and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of the Adviser. The Company might not participate in each individual opportunity, but will, on an overall basis, be entitled to participate equitably with other entities managed by Oaktree and its affiliates. Oaktree is committed to treating all clients fairly and equitably over time such that none receive preferential treatment vis-à-vis the others over time, in a manner consistent with its fiduciary duty to each of them; however, in some instances, especially in instances of limited liquidity, the factors may not result in pro rata allocations or may result in situations where certain funds or accounts receive allocations where others do not.

Pursuant to the Investment Advisory Agreement, the Adviser’s liability is limited and the Company is required to indemnify the Adviser against certain liabilities. This may lead the Adviser to act in a riskier manner in performing its duties and obligations under the Investment Advisory Agreement than it would if it were acting for its own account, and creates a potential conflict of interest.

In addition, the Company may make investments in different parts of the capital structure of companies in which other funds and accounts managed or subadvised by the Adviser (“Other Oaktree Funds”) already hold an investment. Generally speaking, the Adviser expects that the Company will make such investments only when, at the time of investment, the Adviser believes such investment is in the Company’s best interests and either the possibility of actual adversity is remote, the Company’s investment is small and non-controlling or the Adviser believes that such investment is appropriate for us in light of the particular circumstances, notwithstanding the potential for conflict. If any conflict were to arise, however, the Adviser will be permitted to take certain actions that, in the absence of such conflict, it would not take, such as causing the Company to remain passive, investing in the same class of securities to align interests, divesting investments or taking other actions to reduce adversity, which may have the effect of benefiting certain Other Oaktree Funds, and not the Company. Given that the Company generally intends to invest higher in the capital structure, it is likely the Company will remain passive in the event of a conflict, meaning that the Company must rely on other investors holding the same types of securities or obligations to advocate on behalf of the Company’s class. The Adviser has no obligation to advise these other holders of any potential claims they may have of which the Adviser may be created during such periodsaware or to consider their interests when advocating on behalf of market dislocation and volatility, including opportunitiesthe Other Oaktree Funds that hold investments in lower parts of the capital structure.

Under certain circumstances, the Company potentially will be offered an opportunity to make acquisitionsan investment in a transaction in which one or more Other Oaktree Funds is expected to make an investment, or in a company in which one or more Other Oaktree Funds already has made, or concurrently will make, an investment. The Investment Company Act and the exemptive relief also impose restrictions on the Company’s ability to

18


participate in certain transactions with Other Oaktree Funds. As a result, the Company and the Other Oaktree Funds potentially will have conflicting interests in negotiating the terms of such investments. In negotiating the purchase of such investments, the nature of the covenants, and other companiesterms and conditions of such securities, the Other Oaktree Funds potentially will have interests that conflict with the Company’s. In that regard, subject to the requirements of the Investment Company Act and the exemptive relief, actions may be taken for the Other Oaktree Funds that are adverse to the Company. Such conflicts also have the potential to arise in the negotiations of amendments or investment portfolios at compelling value.

However, BDCs as an industry historically have traded below NAVwaivers or in a workout or bankruptcy. It is possible that in a bankruptcy proceeding, the Company’s interests would be subordinated or otherwise adversely affected by virtue of such Other Oaktree Funds’ involvement and actions relating to its investment. The Adviser will seek to manage such conflicts in good faith and in particular, sharesa manner it believes is consistent with its duties to the Company and the Other Oaktree Funds and under the Investment Company Act and the exemptive relief, if applicable.

Pursuant to the Administration Agreement, Oaktree Administrator furnishes the Company with the facilities, including its principal executive office, and administrative services necessary to conduct its day-to-day operations. The Company pays Oaktree Administrator its allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration Agreement, including, without limitation, a portion of the rent at market rates and compensation of the Company’s chief financial officer, chief compliance officer, their respective staffs and other non-investment professionals at Oaktree and its affiliates that perform duties for the Company.

Delinquent Section 16(a) Reports

Section 16(a) of the Exchange Act, requires the Company’s directors and executive officers, and persons who own 10% or more of the Company’s common stock, have traded below NAV. Although sharesto file reports of ownership and changes in ownership of its equity securities with the SEC. Based solely on a review of the Company’s common stock traded at prices above NAVcopies of those forms filed with the SEC, or written representations that no such forms were required, except for one Form 4 filed late by Ashley Pak on April 12, 2023 (reporting one late transaction), the Company believes that its directors, executive officers and 10% or more beneficial owners complied with all Section 16(a) filing requirements during portions of the 2023 fiscal year there can be no assurance that they will tradeended September 30, 2023.

Corporate Governance

Corporate Governance Documents

The Company maintains a corporate governance webpage under the “Investors” link at prices above NAV in the near term or that the premium at which shareshttps://www.oaktreespecialtylending.com. The Corporate Governance Policy, Code of the Company’s common stock may trade in the future will be sufficiently largeBusiness Conduct, Joint Code of Ethics, Securities Trading Policy, Audit Committee Charter, Nominating and Corporate Governance Committee Charter and Compensation Committee Charter for the Company are available at https://www.oaktreespecialtylending.com and are also available to issue sharesany stockholder who requests them by writing to Oaktree Specialty Lending Corporation, 333 South Grand Avenue, 28th Floor, Los Angeles, CA 90071, Attention: Secretary.

Director Independence

In accordance with rules of Nasdaq, the Board annually determines the independence of each director. No director is considered independent unless the Board has determined that he or she has no material relationship with the Company. The Company monitors the status of its directors and officers through the activities of the Nominating and Corporate Governance Committee and through a questionnaire to be completed by each director no less frequently than annually, with updates periodically if information provided in an offering above the then current NAV per share after taking into accountmost recent questionnaire has materially changed.

In order to evaluate the discounts, commissions or feesmateriality of any underwriter, dealer or agent in connection with such offering. Ifrelationship, the current periodBoard uses the definition of market dislocation and volatility continues or another period of market dislocation and volatility were to occur, the Company may not have access to sufficient debt and equity capital in order to take advantage of attractive investment and acquisition opportunities that are created during such period. In addition, the debt capital that will be available, if any, may be at a higher cost and

6

Table of Contents
on less favorable terms and conditionsdirector independence set forth in the future, particularly given the current interest rate environment. Given the potential for instability in the financial markets, including through increased market volatility, stockholder approvalNasdaq listing rules. Section 5605 provides that a director of the Proposal would provide the Company with maximum flexibilitya business

19


development company shall be considered to take advantage of such attractive investment and acquisition opportunities, which typically must be acted upon expeditiously.

Status as a BDC and RIC and Maintaining a Favorable Debt to Equity Ratio
As a BDC and a regulated investment company (“RIC”) for tax purposes, the Company needs to raise equity capital to grow its investment portfolio. As a RIC, the Company generally must distribute substantially all of its earnings to stockholders as dividends in order to qualify for the tax benefits available to RICs, which prevents the Company from retaining meaningful amounts of earnings to support operations, including making new investments. Further, as a BDC, the Company may issue “senior securities,” including borrowing money from banksindependent if he or other financial institutions, only in amounts such that the Company’s asset coverage, as defined in the 1940 Act, equals at least 150% after such incurrence or issuance. Certain of the Company’s debt facilities also require that it maintain suchshe is not an asset coverage ratio. These limitations may prevent the Company from incurring debt to grow its investment portfolio.
In addition, failure to maintain the asset coverage required by the 1940 Act or by any debt facility could have severe negative consequences for the Company, including the inability to pay dividends and breach of debt covenants. Although the Company is in compliance with, and does not currently expect that it will breach, the allowable asset coverage ratios, the markets it operates in and the general economy have experienced volatility in the past and may become volatile again in the future. Even if the underlying performance of one or more portfolio companies may not indicate an impairment or inability to repay all principal and interest in full, volatility in the capital markets may negatively impact the valuations of investments and create unrealized capital depreciation on certain investments. Any such write-downs in value (as well as unrealized capital depreciation based on the underlying performance of the Company’s portfolio companies, if any) will negatively impact the Company’s total assets and the resulting asset coverage ratio. Issuing additional equity would allow the Company to realign its asset coverage ratio and avoid these negative consequences. In addition to meeting legal requirements applicable to BDCs, having a more favorable asset coverage and debt to equity ratio would also generally strengthen the Company’s balance sheet, potentially improve access to the debt markets and provide greater flexibility for the Company to fully execute its business strategy.
Board Approval
The Board, including all of the directors who have no financial interest in the Proposal and all of the directors who are not “interested persons”person” of the Company, as defined in Section 2(a)(19) of the 1940Investment Company Act. Section 2(a)(19) of the Investment Company Act defines an “interested person” to include, among other things, any person who has, approvedor within the Proposallast two years had, a material business or professional relationship with the Company.

The Board has determined that each of the current directors is, and each director that served during fiscal year 2023, was independent and has no relationship with the Company, except as in the best interestsa director and stockholder of the Company, with the exception of Mr. Frank. Mr. Frank is an interested person of the Company due to his positions at Oaktree.

Evaluation

The Company’s directors perform an evaluation, no less frequently than annually, of the effectiveness of the Board and its stockholderscommittees. This evaluation includes Board and recommends itBoard committee discussions.

Communications with Directors

Stockholders and other interested parties may contact any member (or all members) of the Board by mail. To communicate with the Board, any individual director or any group or committee of directors, correspondence should be addressed to the stockholdersBoard or any such individual director or group or committee of directors by either name or title. All such correspondence should be sent to Oaktree Specialty Lending Corporation, 333 South Grand Avenue, 28th Floor, Los Angeles, CA 90071, Attention: Secretary. Any communication to report potential issues regarding accounting, internal controls and other auditing matters will be directed to the Audit Committee. Appropriate personnel of the Company will review and sort through communications before forwarding them to the addressee(s).

Board Meetings and Committees

The Board met five times during fiscal year 2023. Each director attended at least 75% of the total number of meetings of the Board and committees during fiscal year 2023 on which the director served that were held while the director was a member of the Board or such committee, as applicable. The Board’s standing committees are described below. Directors are encouraged to attend each annual meeting of stockholders. Four of the directors attended the Company’s 2023 annual meeting of stockholders.

Audit Committee

The Audit Committee is responsible for selecting, engaging and discharging the Company’s independent accountants, reviewing the plans, scope and results of the audit engagement with its independent accountants, approving professional services provided by its independent accountants (including compensation thereof), reviewing the independence of its independent accountants and reviewing the adequacy of its internal control over financial reporting, as well as establishing guidelines and making recommendations to the Board regarding the valuation of its loans and investments.

The current members of the Audit Committee are Messrs. Jacobson and Zimmerman and Mses. Caldwell and Gero, each of whom is not an interested person of the Company as defined in the Investment Company Act and is independent for purposes of the Nasdaq listing rules. Ms. Gero currently serves as the Chair of the Audit Committee. The Board has determined that Ms. Gero is an “audit committee financial expert” as defined under SEC rules. The Audit Committee met eight times during fiscal year 2023.

Compensation Committee

The Compensation Committee is responsible for reviewing and approving the reimbursement by the Company of the allocable portion of the compensation of its chief financial officer and chief compliance officer

20


and their approval. For theserespective staffs and other non-investment professionals at Oaktree and its affiliates that perform duties for the Company.

The current members of the Compensation Committee are Messrs. Jacobson and Zimmerman and Mses. Caldwell and Gero, each of whom is not an interested person of the Company as defined in the Investment Company Act and is independent for purposes directors are not deemed to have a financial interest solely by reason of their ownershipthe Nasdaq listing rules. Mr. Jacobson serves as the Chair of the Compensation Committee. As discussed below, none of the Company’s common stock.

executive officers is directly compensated by the Company. The Compensation Committee met two times during fiscal year 2023.

Nominating and Corporate Governance Committee

The Nominating and Corporate Governance Committee is responsible for determining criteria for service on the Board, believes that havingidentifying, researching and nominating directors for election by its stockholders, selecting nominees to fill vacancies on the flexibilityBoard or a committee of the Board, developing and recommending to issue common stock below NAV per share in certain instancesthe Board a set of corporate governance principles and overseeing the self-evaluation of the Board and its committees and evaluation of management.

The members of the Nominating and Corporate Governance Committee are Messrs. Jacobson and Zimmerman and Mses. Caldwell and Gero, each of whom is in the best interestsnot an interested person of the Company as defined in the Investment Company Act and its stockholders. During volatile periods, suchis independent for purposes of the Nasdaq listing rules. Ms. Caldwell currently serves as the current market environment, this would, amongChair of the Nominating and Corporate Governance Committee. The Nominating and Corporate Governance Committee met two times during fiscal year 2023.

The Nominating and Corporate Governance Committee considers qualified director nominees recommended by the Company’s stockholders when such recommendations are submitted in accordance with the Company’s bylaws and any other things,applicable law, rule or regulation regarding director nominations. Stockholders of the Company may submit candidates for nomination for the Board by writing to: Board of Directors, Oaktree Specialty Lending Corporation, 333 South Grand Avenue, 28th Floor, Los Angeles, CA 90071. When submitting a nomination for consideration, a stockholder must provide accesscertain information about each person whom the stockholder proposes to capital marketsnominate for election as a director, including: (i) the name, age, business address and residence address of the person; (ii) the principal occupation or employment of the person; (iii) the class or series and number of shares of Company common stock owned beneficially or of record by the person; and (iv) any other information relating to pursue attractive investment and acquisition opportunities and add financial flexibility to comply with regulatory requirements and debt facility covenants, including the applicable asset coverage ratios. It could also minimize the likelihoodperson that the Company would be required to sell assetsbe disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors pursuant to Section 14 of the Exchange Act, and the rules and regulations promulgated thereunder. Such notice must be accompanied by the proposed nominee’s written consent to be named as a nominee and to serve as a director if elected.

In evaluating director nominees, the Nominating and Corporate Governance Committee considers the following factors:

the appropriate size and composition of the Board;

its needs with respect to the particular talents and experience of its directors;

the knowledge, skills and experience of nominees in light of prevailing business conditions and the knowledge, skills and experience already possessed by other members of the Board;

the capacity and desire to serve as a member of the Board and to represent the balanced, best interests of its stockholders as a whole;

experience with accounting rules and practices; and

the desire to balance the considerable benefit of continuity with the periodic addition of the fresh perspective provided by new members.

21


The Nominating and Corporate Governance Committee’s goal is to assemble a Board that brings it a variety of perspectives and skills derived from high quality business and professional experience.

Other than the foregoing, there are no stated minimum criteria for director nominees, although the Nominating and Corporate Governance Committee may also consider such other factors as it may deem are in the Company’s best interests and those of its stockholders. The Nominating and Corporate Governance Committee does not assign specific weights to particular criteria, and no particular criterion is necessarily applicable to all prospective nominees. The Company believes that the Company wouldbackgrounds and qualifications of the directors, considered as a group, should provide a significant composite mix of experience, knowledge and abilities that will allow the Board to fulfill its responsibilities. Other than the requirements of applicable law or Nasdaq listing rules, the Board does not otherwise sell, which sales could occur at timeshave a specific diversity policy, but considers diversity of race, religion, national origin, gender, sexual orientation, disability, cultural background and at pricesprofessional experiences in evaluating candidates for Board membership.

The Nominating and Corporate Governance Committee identifies nominees by first evaluating the current members of the Board willing to continue in service. Current members of the Board with skills and experience that are disadvantageousrelevant to the Companyapplicable business and its stockholders.

Whilewho are willing to continue in service are considered for re-nomination, balancing the value of continuity of service by existing members of the Board with that of obtaining a new perspective. If any member of the Board does not wish to continue in service or if the Nominating and Corporate Governance Committee or the Board decides not to re-nominate a member for re-election or the Board decides to add a new director to the Board, the Nominating and Corporate Governance Committee would identify the desired skills and experience of a new nominee in light of the criteria above. Current members of the Nominating and Corporate Governance Committee and the Board would review and discuss, for nomination, the individuals meeting the criteria of the Nominating and Corporate Governance Committee. Research may also be performed to identify qualified individuals. The Nominating and Corporate Governance Committee has not, but may choose to, engage an independent consultant or other third party to identify or evaluate or assist in identifying potential nominees to the Board.

Co-Investment Committee

The Co-Investment Committee is responsible for reviewing and approving certain co-investment transactions in accordance with the conditions of the exemptive order the Company has no immediate plansreceived from the SEC. The charter of the Company’s Co-Investment Committee is available in print to issue any sharesstockholder who requests it.

The current members of its common stock below NAV, itthe Co-Investment Committee are Messrs. Frank, Jacobson and Zimmerman and Mses. Caldwell and Gero, each of whom is seeking stockholder approval now in order to provide flexibility if it desiresnot an interested person of the Company as defined in the futureInvestment Company Act and is independent for purposes of the Nasdaq listing rules, with the exception of Mr. Frank who is an interested person as defined in the Investment Company Act. Mr. Zimmerman currently serves as the Chair of the Co-Investment Committee.

Code of Business Conduct

The Company has adopted a Code of Business Conduct which applies to, issue sharesamong others, executive officers, including the principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions and all other officers, employees and directors of its common stock below NAV per share, which typically must be undertaken quickly. The final terms of any such sale will be determined by the Board at the time of issuance, and the shares of common stock will not include

7

Table of Contents
preemptive rights. Also, becauseCompany. If the Company makes any substantive amendment to, or grants a waiver from, a provision of the Code of Business Conduct, the Company will promptly disclose the nature of the amendment or waiver on its website at https://www.oaktreespecialtylending.com.

Securities Trading Policy

The Company has no immediate plans to issue any shares of its common stock below NAV per share, it is not possible to describe theadopted a Securities Trading Policy that, among other things, prohibits directors, officers and other employees from entering into a short sale transaction or transactions in which such sharesputs, calls or other derivative

22


securities, on an exchange or in any other organized market, with respect to the Company’s securities or use any other derivative transaction or instrument to take a short position in respect of common stock would be issued. Instead,the Company’s securities. The Securities Trading Policy permits share pledges in limited cases with the pre-approval of the Company’s chief compliance officer.

During the fiscal year ended September 30, 2023, none of our officers or directors adopted or terminated any transaction in whichcontract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement”. During the fiscal year ended September 30, 2023, the Company issues such sharesdid not adopt or terminate any Rule 10b5-1 trading arrangement.

Executive Compensation

The Company’s executive officers do not receive direct compensation from the Company. The compensation of commonthe principals and other investment professionals of the Adviser are paid by Oaktree or one of its affiliates. Further, the Company is prohibited under the Investment Company Act from issuing equity incentive compensation, including stock includingoptions, stock appreciation rights, restricted stock and stock, to its officers or directors, or any employees it may have in the naturefuture. Compensation paid to the Company’s chief financial officer and amount of considerationchief compliance officer and their respective staffs and other non- investment professionals at Oaktree that would be receivedperform duties for the Company is set by Oaktree Administrator and is subject to reimbursement by the Company atof an allocable portion of such compensation for services rendered to it.

During fiscal year 2023, $1.3 million was incurred by, and $0.9 million was reimbursed to, the time of issuance and the use of any such consideration, will be reviewed and approvedOaktree Administrator by the Board atCompany for the timeallocable portion of issuance. Ifcompensation expenses incurred by the Proposal is approved, no further authorization from the stockholders will be solicited prior to any such issuance in accordance with the termsOaktree Administrator on behalf of the Proposal. If approved, the authorization would be effective for common stock issued during a twelve-month period following stockholder approvalchief financial officer, chief compliance officer and other support personnel of the Proposal.

Trading History
Company pursuant to the Administration Agreement.

Director Compensation

The following table sets forth for each fiscal quarter during the last three fiscal years and current fiscal year, the Company’s NAV per share (where it has been determined), the range of high and low sales pricescompensation of the Company’s common stock as reported on The Nasdaq Global Select Market (“Nasdaq”) anddirectors for the premium (discount) of such sales price to the Company’s NAV per share. On January 4, 2024, the last reported sales price of the Company’s common stock on Nasdaq was $21.01 per share, which represented a premium of approximately 7.0% to the NAV per share reported by the Company as offiscal year ended September 30, 2023. Figures for periods prior to January 23, 2023 have been adjusted to give effect to the 1 for 3 reverse stock split completed on January 20, 2023 and effective at the commencement of trading on January 23, 2023.

       
Sales Price
   
Premium
(Discount) of
High Sales Price
to NAV (2)
  
Premium
(Discount) of
Low Sales Price
to NAV (2)
 
   
NAV (1)
   
High
   
Low
 
Year ended September 30, 2021
         
First quarter
  $20.55   $16.98   $13.56    (17.4)%   (34.0)% 
Second quarter
  $21.27   $19.08   $16.41    (10.3)%   (22.8)% 
Third quarter
  $21.66   $20.76   $18.57    (4.2)%   (14.3)% 
Fourth quarter
  $21.84   $22.20   $19.74    1.6  (9.6)% 
Year ended September 30, 2022
         
First quarter
  $22.03   $22.86   $21.09    3.8  (4.3)% 
Second quarter
  $21.79   $23.43   $21.39    7.5  (1.8)% 
Third quarter
  $20.67   $22.83   $18.60    10.4  (10.0)% 
Fourth quarter
  $20.38   $21.75   $17.61    6.7  (13.6)% 
Year ended September 30, 2023
         
First quarter
  $19.63   $21.69   $17.58    10.5  (10.4)% 
Second quarter
  $19.66   $21.48   $17.70    9.3  (10.0)% 
Third quarter
  $19.58   $20.05   $17.99    2.4  (8.1)% 
Fourth quarter
  $19.63   $20.71   $19.24    5.5  (2.0)% 
Year ending September 30, 2024
         
First quarter
   *   $20.79   $18.41    *   * 
Second quarter (through January 8, 2024)
   *   $21.12   $20.24    *   * 
*
Not determinable at the time of filing.
2023:

Name

  Fees
Earned
or
Paid in
Cash(1)(2)
   Total
Compensation
from the
Company
   Total
Compensation
from the
Fund
Complex(3)
 

Interested Directors:

      

John B. Frank

   —      —      —   

Independent Directors:

      

Phyllis Caldwell

  $150,000   $150,000   $150,000 

Deborah Gero

  $175,000   $175,000   $268,306(4) 

Craig Jacobson

  $150,000   $150,000   $150,000 

Bruce Zimmerman

  $165,000   $165,000   $165,000 

(1)NAV per share is determined as

For a discussion of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low sales prices. The NAVs shown are based on outstanding shares at the end of each period.independent directors’ compensation, see below.

(2)Calculated

The Company does not maintain a stock or option plan, non-equity incentive plan or pension plan for its directors.

(3)

“Fund Complex” includes the Company, OLPG and OSCF, each a business development company advised by the Adviser.

(4)

Includes compensation paid to Ms. Gero in connection with her service as a director of OSI2, a business development company advised by the respective high or low sales price less NAV per share, divided by NAV per share.Adviser, prior to the completion of the OSI2 Merger.

23


Examples

For fiscal year 2023, each independent director received an annual retainer fee of Dilutive Effect$150,000. In addition, the lead independent director and Chair of the IssuanceAudit Committee received an additional $15,000 and $25,000, respectively. The Board has adopted a policy which, over a period of Shares Below NAV

Sales by ustime, requires each independent director to hold Company stock equal to at least the compensation paid to such director in the prior fiscal year. No compensation was paid to directors who were interested persons of our common stock at a discount from NAV per share pose potential risksthe Company as defined in the Investment Company Act. The independent directors review and determine their compensation.

24


PROPOSAL 2 — RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE 2024 FISCAL YEAR

Upon the recommendation of the Audit Committee of the Board, the Board has retained EY as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2024, subject to ratification by the Company’s existing stockholders whether or not they participate in an offering, as well as for new investors whostockholders.

It is expected that a representative of EY will participate in the offering. Any sale of common stock atAnnual Meeting and will have an opportunity to make a price below NAV per share would result in an immediate dilutionstatement if he or she chooses and will be available to existing stockholders who do not participate in such sale on at least

a pro-rata basis.
8

answer questions.

Table of Contents

Independent Auditor’s Fees

The following three headingstable presents fees for professional services rendered by EY for the fiscal years ended September 30, 2023 and accompanying tables explain and provide hypothetical examples on2022.

   2023  2022 

Audit Fees

  $1,290,000  $1,280,000 

Audit-Related Fees

  $122,000  $—   

Aggregate Non-Audit Fees:

   

Tax Fees

  $286,200  $275,500 

All Other Fees

   —     —   

Total Aggregate Non-Audit Fees

  $286,200(1)  $275,500(2) 

Total Fees

  $1,698,200  $1,555,500 

(1)

Non-audit fees represent 16.9% of total fees.

(2)

Non-audit fees represent 17.7% of total fees.

Audit Fees. Audit fees consist of fees billed for professional services rendered for the impact of a public offeringaudit of the Company’s common stock at a price less than NAV on three different typesyear-end financial statements and services that are normally provided by the independent registered public accounting firm in connection with statutory and regulatory filings.

Audit-Related Fees. Audit-related services consist of investors:

existing stockholders who do not purchase any shares in the offering;
existing stockholders who purchase a relatively small amount of shares in the offering or a relatively large amount of shares in the offering;fees billed for assurance and
new investors who become stockholders by purchasing shares in the offering.
A placement of common stock at a price less than NAV per share to a third party in a private placement would have an impact substantially similar related services that are reasonably related to the impact on existing stockholders who do not purchase any shares in the public offering described below.
Impact on Existing Stockholders Who Do Not Participate in the Offering
The Company’s existing stockholders who do not participate in an offering below NAV per share or who do not buy additional shares in the secondary market at the same or lower price as the Company obtains in the offering (after expenses and commissions) face the greatest potential risks. These stockholders will experience an immediate dilution in the NAVperformance of the shares of common stock they hold. These stockholders will also experience a disproportionately greater decrease in their participation in the Company’s earnings and assets and their voting power than the increase the Company will experience in its assets, potential earning power and voting interests due to such offering. These stockholders may also experience a decline in the market price of their shares, which often reflects to some degree announcedaudit or potential decreases in NAV per share. This decrease could be more pronounced as the size of the offering and level of discount increases. Further, if current stockholders do not purchase any shares to maintain their percentage interest, regardless of whether such offering is above or below NAV per share, their voting power will be diluted.
The examples assume that the Company has 1,000,000 shares of common stock outstanding, $15,000,000 in total assets and $5,000,000 in total liabilities. The current NAV of the Company and NAV per share are thus $10,000,000 and $10.00, respectively. The table below illustrates the dilutive effect on nonparticipating Stockholder A of (1) an offering of 50,000 shares (5% of the outstanding shares) at $9.50 per share after offering expenses and commissions (a 5% discount from NAV); (2) an offering of 100,000 shares (10% of the outstanding shares) at $9.00 per share after offering expenses and commissions (a 10% discount from NAV); (3) an offering of 250,000 shares (25% of the outstanding shares) at $7.50 per share after offering expenses and commissions (a 25% discount from NAV); and (4) an offering of 250,000 shares (25% of the outstanding shares) at $0.00 per share after offering expenses and commissions (a 100% discount from NAV). The prospectus pursuant to which any discounted offering is made will include a chart for these examples based on the actual number of shares in such offering and the actual discount from the most recently determined NAV per share. It is not possible to predict the level of market price decline that may occur. These examples are provided for illustrative purposes only.
  
Prior to

Sale

Below NAV
  
Example 1

5% Offering

at 5% Discount
  
Example 2

10% Offering

at 10% Discount
  
Example 3

25% Offering

at 25% Discount
  
Example 4

25% Offering

at 100% Discount
 
  
Following

Sale
  
%

Change
  
Following

Sale
  
%

Change
  
Following

Sale
  
%

Change
  
Following

Sale
  
%

Change
 
Offering Price
         
Price per share to public  —    $10.00   —    $9.47   —    $7.89   —    $0.00   —   
Net proceeds per share to issuer  —    $9.50   —    $9.00   —    $7.50   —    $0.00   —   
Decrease to NAV
         
Total shares outstanding  1,000,000   1,050,000   5.00  1,100,000   10.00  1,250,000   25.00  1,250,000   25.00
NAV per share $10.00  $9.98   (0.20)%  $9.91   (0.90)%  $9.50   (5.00)%  $8.00   (20.00)% 
9

  
Prior to

Sale

Below NAV
  
Example 1

5% Offering

at 5% Discount
  
Example 2

10% Offering

at 10% Discount
  
Example 3

25% Offering

at 25% Discount
  
Example 4

25% Offering

at 100% Discount
 
  
Following

Sale
  
%

Change
  
Following

Sale
  
%

Change
  
Following

Sale
  
%

Change
  
Following

Sale
  
%

Change
 
Dilution to Stockholder
         
Shares held by Stockholder A  10,000   10,000   —     10,000   —     10,000   —     10,000   —   
Percentage held by Stockholder A  1.00  0.95  (5.00)%   0.91  (9.00)%   0.80  (20.00)%   0.80  (20.00)% 
Total Asset Values
         
Total net asset value held by Stockholder A $100,000  $99,800   (0.20)%  $99,100   (0.90)%  $95,000   (5.00)%  $80,000   (20.00)% 
Total investment by Stockholder A (assumed to be $10.00 per Share) $100,000  $100,000   —    $100,000   —    $100,000   —    $100,000   —   
Total dilution to Stockholder A (total NAV less total investment)  —    $(200  —    $(900  —    $(5,000  —    $(20,000  —   
Per Share Amounts
         
NAV held by Stockholder A  —    $9.98   —    $9.91   —    $9.50   —    $8.00   —   
Investment per share held by Stockholder A (assumed to be $10.00 per share on shares held prior to sale) $10.00  $10.00   —    $10.00   —    $10.00   —    $10.00   —   
Dilution per share held by Stockholder A (NAV less investment per share)  —    $(0.02  —    $(0.09  —    $(0.50  —    $(2.00  —   
Percentage dilution to Stockholder A (dilution per share divided by investment per share)  —     —     (0.20)%   —     (0.90)%   —     (5.00)%   —     (20.00)% 
Impact on Existing Stockholders Who Do Participate in the Offering
The Company’s existing stockholders who participate in an offering below NAV or who buy additional shares in the secondary market at the same or lower price as the Company obtains in the offering (after expenses and commissions) will experience the same types of NAV dilution as the nonparticipating stockholders, although at a lower level, to the extent they purchase less than the same percentage of the discounted offering as their interest in sharesreview of the Company’s common stock immediately priorfinancial statements and are not reported under “Audit Fees.” These services include attest services that are not required by statute or regulation and consultations concerning financial accounting and reporting standards.

Tax Fees. Tax fees consist of fees billed for professional services for tax compliance. These services include assistance regarding federal, state and local tax compliance.

All Other Fees. All other fees would include fees for products and services other than the services reported above.

Aggregate Non-Audit Fees. Aggregate non-audit fees billed by EY to Oaktree and its affiliates who provide on-going services to the offering.Company during the fiscal year ended September 30, 2023 was $8,322,000. The levelAudit Committee does not consider the provision of NAV dilutionsuch services to be incompatible with maintaining EY’s independence.

Required Vote

The affirmative vote of a majority of the votes cast at the Annual Meeting in person or by proxy is required to approve this proposal. Abstentions will decrease asnot be included in determining the number of shares such stockholders purchase increases. Existing stockholders who buy more than such percentagevotes cast and, as a

25


result, will experience NAV dilution buthave no effect on this proposal. Because brokers will in contrasthave discretionary authority to existing stockholders who purchase less than their proportionate sharevote for the ratification of the offering, experience accretion in NAV over their investment per share and will also experience a disproportionately greater increase in their participationselection of the Company’s registered independent public accounting firm in the Company’s earnings and assets and theirevent that they do not receive voting power than the Company’s increase in assets, potential earning power and voting interests due to such offering. The level of accretion will increase as the excess number of shares such

10

Table of Contents
stockholder purchases increases. Even a stockholder who over-participates will, however, be subject to the risk that the Company may make additional discounted offerings in which such stockholder does not participate, in which case such a stockholder will experience NAV dilution as described above in such subsequent offerings. These stockholders may also experience a decline in the market price of their shares, which often reflects to some degree announced or potential decreases in NAV. This decrease could be more pronounced as the size of the offering and level of discounts increases.
The following table illustrates the dilutive and accretive effect in the hypothetical 25% discount offeringinstructions from the prior chart for Stockholder A that acquires shares equal to (1) 50% of their proportionate share of the offering (i.e., 1,250 shares, which is 0.50% of the offering of 250,000 shares rather than their 1.00% proportionate share) and (2) 150% of their proportionate share of the offering (i.e., 3,750 shares, which is 1.50% of the offering of 250,000 shares rather than their 1.00% proportionate share). The prospectus pursuant to which any discounted offering is made will include a chart for these examples based on the actual number of shares in such offering and the actual discount from the most recently determined NAV. It is not possible to predict the level of market price decline that may occur. These examples are provided for illustrative purposes only.
   
Prior to

Sale Below

NAV
  
50% Participation
  
150% Participation
 
  
Following

Sale
  
%

Change
  
Following

Sale
  
%

Change
 
Offering Price
      
Price per share to public   —    $7.89   —    $7.89   —   
Net proceeds per share to issuer   —    $7.50   —    $7.50   —   
Increases in Shares and Decrease to NAV
      
Total shares outstanding   1,000,000   1,250,000   25.00  1,250,000   25.00
NAV per share  $10.00  $9.50   (5.00)%  $9.50   (5.00)% 
(Dilution)/Accretion to Participating Stockholder A
      
Shares held by Stockholder A   10,000   11,250   12.50  13,750   37.50
Percentage held by Stockholder A   1.00  0.90  (10.00)%   1.10  10.00
Total Asset Values
      
Total NAV held by Stockholder A  $100,000  $106,875   6.88 $130,625   30.63
Total investment by Stockholder A (assumed to be $10.00 per share on shares held prior to sale)  $100,000  $109,863   9.86 $129,588   29.59
Total (dilution)/accretion to Stockholder A (total NAV less total investment)   —    $(2,988  —    $1,037   —   
Per Share Amounts
      
NAV held by Stockholder A   —    $9.50   —    $9.50   —   
Investment per share held by Stockholder A (assumed to be $10.00 per share on shares held prior to sale)  $10.00  $9.77   (2.30)%  $9.42   (5.80)% 
(Dilution)/accretion per share held by Stockholder A (NAV less investment per share)   —    $(0.27  —    $0.08   —   
Percentage (dilution)/accretion to Stockholder A (dilution/accretion per share divided by investment per share)   —     —     (2.76)%   —     0.85
Impact on New Investors
Investors who are not currently stockholders and who participate in an offeringbeneficial owner of shares of the Company’s common stock, below NAV, but whose investment per share is greater than the resulting NAV per share due to selling compensation and expenses paid by the Company, will experience an immediate decrease, although small, in the NAV of their shares and their NAV per share compared to the price they pay for their shares. Investors who are not currently stockholders and who participate in an offering of shares of the Company’s common stock below NAV and whose investment per share is also less than the resulting NAV per share due to selling
11

Table of Contents
compensation and expenses paid by the Company being significantly less than the discount per share, will experience an immediate increase in the NAV of their shares and their NAV per share compared to the price they pay for their shares. These investors will experience a disproportionately greater participation in the Company’s earnings and assets and their voting power than the Company’s increase in assets, potential earning power and voting interests due to such offering. These investors will, however, be subject to the risk that the Company may make additional discounted offerings in which such new stockholder does not participate, in which case such new stockholder will experience dilution as described above in such subsequent offerings. These investors may also experience a decline in the market price of their shares, which often reflects to some degree announced or potential decreases in NAV. This decrease could be more pronounced as the size of the offering and level of discounts increases.
The following table illustrates the dilutive and accretive effects on Stockholder A who purchases the same percentage (1.00%) of the shares in three hypothetical offerings of common stock of different sizes and levels of discount from NAV: (1) an offering of 50,000 shares (5% of the outstanding shares) at $9.50 per share after offering expenses and commissions (a 5% discount from NAV); (2) an offering of 100,000 shares (10% of the outstanding shares) at $9.00 per share after offering expenses and commissions (a 10% discount from NAV); (3) an offering of 250,000 shares (25% of the outstanding shares) at $7.50 per share after offering expenses and commissions (a 25% discount from NAV); and (4) an offering of 250,000 shares (25% of the outstanding shares) at $0.00 per share after offering expenses and commissions (a 100% discount from NAV). The prospectus pursuant to which any discounted offering is made will include a chart for these examples based on the actual number of shares in such offering and the actual discount from the most recently determined NAV. It is not possible to predict the level of market price decline that may occur. These examples are provided for illustrative purposes only.
  
Example 1

5% Offering at

5% Discount
  
Example 2

10% Offering

at 10% Discount
  
Example 3

25% Offering

at 25% Discount
  
Example 4

25% Offering

at 100% Discount
 
  
Prior to
Sale

Below NAV
  
Following

Sale
  
%

Change
  
Following

Sale
  
%

Change
  
Following

Sale
  
%

Change
  
Following

Sale
  
%

Change
 
Offering Price
         
Price per share to public  —    $10.00   —    $9.47   —    $7.89   —    $0.00   —   
Net offering proceeds per share to issuer  —    $9.50   —    $9.00   —    $7.50   —    $0.00   —   
Decrease to NAV
         
Total shares outstanding  1,000,000   1,050,000   5.00  1,100,000   10.00  1,250,000   25.00  1,250,000   25.00
NAV per share  10.00  $9.98   (0.20)%  $9.91   (0.90)%  $9.50   (5.00)%  $8.00   (20.00)% 
Dilution to Stockholder A
         
Shares held by Stockholder A  —     500   —     1,000   —     2,500   —     2,500   —   
Percentage held by Stockholder A  —     0.05  —     0.09  —     0.20  —     0.20  —   
Total Asset Values
         
Total NAV held by Stockholder A  —    $4,990   —    $9,910   —    $23,750   —    $20,000   —   
Total investment by Stockholder A  —    $5,000   —    $9,470   —    $19,725   —    $0.00   —   
Total (dilution)/accretion to Stockholder A (total NAV less total investment)  —    $(10  —    $440   —    $4,025   —    $20,000   —   
12

  
Example 1

5% Offering at

5% Discount
  
Example 2

10% Offering

at 10% Discount
  
Example 3

25% Offering

at 25% Discount
  
Example 4

25% Offering

at 100% Discount
 
  
Prior to
Sale

Below NAV
  
Following

Sale
  
%

Change
  
Following

Sale
  
%

Change
  
Following

Sale
  
%

Change
  
Following

Sale
  
%

Change
 
Per Share Amounts
         
NAV held by Stockholder A  —    $9.98   —    $9.91   —    $9.50   —    $8.00   —   
Investment per share held by Stockholder A  —    $10.00   —    $9.47   —    $7.89   —    $0.00   —   
(Dilution)/accretion per share held by Stockholder A (NAV less investment per share)  —    $(0.02  —    $0.44   —    $1.61   —    $8.00   —   
Percentage (dilution)/accretion to Stockholder A ((dilution)/accretion per share divided by investment per share)  —     —     (0.20)%   —     4.65  —     20.41  —    
Conditions to Sales Below NAV
If the Company’s stockholders approve the Proposal, the Company will only issue shares of its common stock at a price below NAV per share pursuant to such approval if the following conditions are met:
a “required majority” of the Company’s directors have determined that any such sale would be in the best interests of the Company and its stockholders; and
a “required majority” of the Company’s directors, in consultation with the underwriter or underwriters of the offering (if it is to be underwritten), have determined in good faith, and as of a time immediately prior to the first solicitation by or on behalf of the Company of firm commitments to purchase such common stock or immediately prior to the issuance of such common stock, that the price at which such shares of common stock are to be sold is not less than a price which closely approximates the market value of those shares of common stock, less any distributing commission or discount.
Under the 1940 Act, a “required majority” of directors means both a majority of the Company’s directors who have no financial interest in the transaction and a majority of the Company’s directors who are not “interested persons” of the Company as defined in Section 2(a)(19) of the 1940 Act. For these purposes, directors willthere should not be deemed to have a financial interest solely by reason of their ownership of the Company’s common stock.
Key Stockholder Considerations
Before voting on the Proposal or giving proxiesany broker non-votes with regardrespect to this matter, stockholders should consider the potentially dilutive effect of the issuance of shares of the Company’s common stock at a price that is less than NAV per share and the expenses associated with such issuance. Any sale of common stock at a price below NAV per share would result in an immediate dilution to existing common stockholders who do not participate in such sale on at least a pro rata basis. This dilution would include reduction in NAV per share as a result of the issuance of shares at a price below NAV per share and a proportionately greater decrease in a stockholder’s interest in the
13

earnings and assets of the Company and voting interest in the Company than the increase in the assets of the Company resulting from such issuance.
The 1940 Act establishes a connection between market price and NAV per share because, when common stock is sold or otherwise issued at a sale price below NAV per share, the resulting increase in the number of outstanding shares is not accompanied by a proportionate increase in the net assets of the issuer. proposal.

The Board will consider the potential dilutive effect of the issuance of shares of common stock at a price below NAV per share when considering whether to authorize any such issuance pursuant to the stockholder approval being sought here.

Stockholders should also consider that they will have no subscription, preferential or preemptive rights to additional shares of the common stock proposed to be authorized for issuance pursuant to the Proposal, and thus any future issuance of common stock at a price below NAV per share will dilute such stockholders’ holdings of common stock as a percentage of shares outstanding to the extent such stockholders do not purchase sufficient shares of common stock in the offering or otherwise to maintain their percentage interest. Further, if current stockholders of the Company do not purchase any shares of common stock to maintain their percentage interest, regardless of whether such offering is above or below the then current NAV per share, their voting power will be diluted.
As discussed above, it should be noted that the maximum number of shares of common stock issuable below NAV per share that could result in such dilution is limited to 25% of the Company’s then outstanding common stock.
The Board, including all of the independent directors, recommends a vote “FOR” the Proposal.
14

FINANCIAL STATEMENTS AVAILABLE
We will furnish, without charge, a copyAudit Committee Report

The following is the report of our Annual Report on Form

10-K
the Audit Committee with respect to the Company’s audited financial statements for the fiscal year ended September 30, 2023 to any stockholder upon request. Requests should be directed to Oaktree Specialty Lending Corporation, 1301 Avenue2023.

As part of its oversight of the Americas, 34th Floor, New York, NY 10019,Company’s financial statements, the Audit Committee reviewed and discussed with both management and its independent registered public accounting firm the Company’s audited financial statements filed with the SEC as of and for the fiscal year ended September 30, 2023. The Company’s management advised the Audit Committee that all financial statements were prepared in accordance with U.S. generally accepted accounting principles (GAAP), and reviewed significant accounting issues with the Audit Committee. The Audit Committee discussed with its independent registered public accounting firm the matters required to be discussed by telephoneAuditing Standards No. 1301 (Communication with Audit Committees). The independent registered public accounting firm also provided to the Audit Committee the written disclosures and letter required by applicable requirements of the Public Company Accounting Oversight Board regarding the independent registered public accounting firm’s communications with the Audit Committee concerning independence, and the Audit Committee discussed the subject of independence with the independent registered public accounting firm.

The Audit Committee has established a pre-approval policy that describes the permitted audit, audit-related, tax and other services to be provided by its independent registered public accounting firm. Pursuant to the policies, the Audit Committee pre-approves the audit and non-audit services performed by the independent registered public accounting firm in order to assure that the provision of such services does not impair the firm’s independence.

Any requests for audit, audit-related, tax, and other services that have not received general pre-approval must be submitted to the Audit Committee for specific pre-approval, irrespective of the amount, and cannot commence until such approval has been granted. Normally, pre-approval is provided at (212)

284-1900
regularly scheduled meetings of the Audit Committee. However, the Audit Committee may delegate pre-approval authority to subcommittees of one or more of its members. The member or members to whom such authority is delegated shall report any pre-approval decisions to the Audit Committee at its next scheduled meeting. The Audit Committee does not delegate its responsibilities to pre-approve services performedby the independent registered public accounting firm to management.

The Audit Committee has reviewed the audit fees paid by the Company to its independent registered public accounting firm. It has also reviewed non-audit services and fees to assure compliance with the Company’s and the Audit Committee’s policies restricting the independent registered public accounting firm from performing services that might impair its independence.

Based on the reviews and discussions referred to above, the Audit Committee recommended to the Board that the financial statements as of and for the year ended September 30, 2023 be included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2023 for filing with the SEC. The Audit Committee also recommended the selection of EY to serve as the independent registered public accounting firm of the Company for the fiscal year ending September 30, 2024.

26


e-mail

November 8, 2023

The Audit Committee

Deborah Gero, Chair

Phyllis Caldwell, Member

Craig Jacobson, Member

Bruce Zimmerman, Member

27

at


ocsl-ir@oaktreecapital.com.

OTHER MATTERS

Stockholder Proposals

Any stockholder proposals submitted pursuant

to Rule 14a-8 under the
Securities Exchange Act of 1934, as amended (the “Exchange Act”) for inclusion in the Company’s proxy statement and form of proxy for the 2025 annual meeting of stockholders must be received by the Company on or before September 21, 2024. Such proposals must also comply with the requirements as to form and substance established by the SEC if such proposals are to be included in the proxy statement and form of proxy. Any such proposal should be mailed to: Oaktree Specialty Lending Corporation, 333 South Grand Avenue, 28th Floor, Los Angeles, CA 90071, Attention: Secretary. Proxies solicited by the Company will confer discretionary voting authority with respect to these proposals, subject to SEC rules governing the exercise of this authority.

Stockholder proposals or director nominations to be presented at an annual meeting of stockholders, other than stockholder proposals submitted pursuant

to Rule 14a-8 under
the Exchange Act, must be delivered to, or mailed and received at, the principal executive offices of the Company not more than 150 days and not less than 120 days prior to the date of the anniversary of the previous year’s annual meeting of stockholders. For the 2025 annual meeting of the Company’s stockholders, the Company must receive such proposals and nominations no earlier than October 5,6, 2024 and no later than November 4,5, 2024. If the annual meeting of stockholders is scheduled to be held on a date more than 30 days prior to or after such anniversary date, stockholder proposals or director nominations must be received no later than the 10th day following the day on which such notice of the date of the 2025 annual meeting of stockholders was mailed or such public disclosure of the date of the annual meeting was made. Proposals and nominations must also comply with the other requirements contained in the Company’s bylaws, including supporting documentation and other information and representations.

Other Business

The Board does not presently intend to bring any other business before the SpecialAnnual Meeting. As to any other business that may properly come before the SpecialAnnual Meeting, however, proxies will be voted in respect thereof in accordance with the discretion of the proxyholders.

Whether or not you expect to participate in the SpecialAnnual Meeting, please follow the instructions provided on the enclosed proxy card or in the instructions that accompanied your proxy materialsNotice of Internet Availability of Proxy Materials to vote via the Internet byor telephone, or by signing, datingrequest, sign, date and returning the enclosedreturn a proxy card so that you may be represented at the SpecialAnnual Meeting. The SpecialAnnual Meeting will be a completely virtual meeting of stockholders and will be conducted exclusively by webcast. To participate in the SpecialAnnual Meeting, visit www.virtualshareholdermeeting.com/ocsl2024smocsl2024 and enter the

16-digit
control number included in your Notice of Internet Availability of Proxy Materials, on the enclosed proxy card you received, or in the instructions that accompanied your proxy materials. Online
check-in
will begin at 10:209:55 a.m., Pacific Time (1:20(12:55 p.m., Eastern Time). Please allow time for online
check-in
procedures. For questions regarding the SpecialAnnual Meeting and voting, please contact the Company by calling collect at
(213) 830-6300,
by
e-mail
at
ocsl-ir@oaktreecapital.com,
or by writing to Oaktree Specialty Lending Corporation, 333 South Grand Avenue, 28th Floor, Los Angeles, CA 90071, Attention: Secretary.
15

Table of Contents

Delivery of Proxy Materials

Please note that only one copy of this proxy statement, the Company’s Annual Report on Form 10-K for the year ended September 30, 2023 or Notice of Virtual SpecialAnnual Meeting may be delivered to two or more stockholders of record of the Company who share an address unless we have received contrary instructions from one or more of such stockholders. We will deliver promptly, upon request, a separate copy of any of these documents to stockholders of record at a shared address to which a single copy of such document(s) was delivered.

28


Stockholders who wish to receive a separate copy of any of these documents, or to receive a single copy of such documents if multiple copies were delivered, now or in the future, should submit their request by calling us collect at (213)

830-6300
or by writing to Oaktree Specialty Lending Corporation, 333 South Grand Avenue, 28th Floor, Los Angeles, CA 90071, Attention: Secretary.
Additional Information
The principal address of Oaktree Fund Advisors, LLC, the Company’s investment adviser, and Oaktree Administrator is 333 South Grand Avenue, 28th Floor, Los Angeles, CA 90071.

Available Information

The Company files periodic reports, current reports, proxy statements and other information with the SEC. This information is available on the SEC’s website at www.sec.gov. This information, including the Company’s most recent Annual Report on Form

10-K,
is also available free of charge by calling us collect at (213)
830-6300,
by
e-mail
at
ocsl-ir@oaktreecapital.com,
or by writing to Oaktree Specialty Lending Corporation, 333 South Grand Avenue, 28th Floor, Los Angeles, CA 90071, Attention: Secretary, or on our website at https://www.oaktreespecialtylending.com. The information on our website is not incorporated by reference into this proxy statement.

29

16


Table of Contents

LOGO

OAKTREE SPECIALTY LENDING CORPORATION

333 SOUTH GRAND AVENUE, 28TH FLOOR

LOS ANGELES, CA 90071

  
LOGO

    LOGO

VOTE BY INTERNET

Before The Meeting

- Go to
www.proxyvote.com
or scan the QR Barcode above

Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.

During The Meeting

- Go to
www.virtualshareholdermeeting.com/ocsl2024sm
OCSL2024

You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions.

VOTE BY PHONE - 1-800-690-6903

Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions.

VOTE BY MAIL

Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.

TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:

V27397-P01728                              KEEP THIS PORTION FOR YOUR RECORDS

— — — — — — — — — — — — —— — — — —— — — — — — — — — — — — — — — — — —— — — — — — —— — — — —

DETACH AND RETURN THIS PORTION ONLY

THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.

TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
V27361-S77915KEEP THIS PORTION FOR YOUR RECORDS
DETACH AND RETURN THIS PORTION ONLY
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.

OAKTREE SPECIALTY LENDING CORPORATION

      

The Board of Directors recommends you vote FOR each of the following nominees.

             
 

Votes on Directors

             

 

1.  To elect two directors of the Company, who will serve until the Company’s 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualifies:

For

Withhold Authority

        

1a.  Deborah Gero

1b.  Craig Jacobson

The Board of Directors recommends you vote FOR the following proposal.

    
For
  
Against
 
Abstain
1.

Votes on Proposal

ForAgainstAbstain

2.  To authorizeratify the appointment of Ernst & Young LLP as the Independent Registered Public Accounting Firm for the Company withfor the approval of the Board of Directors, to sell or otherwise issue shares of its common stock at a price below its then current net asset value per share, provided that the number of shares issued does not exceed 25% of its then outstanding common stock.fiscal year ending September 30, 2024.

     

THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED AS DIRECTED OR, IF NO DIRECTION IS GIVEN, WILL BE VOTED AS THE BOARD OF DIRECTORS RECOMMENDS.

      

Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.

        
         

Signature [PLEASE SIGN WITHIN BOX]  Date    Signature (Joint Owners)  Date    



Table of Contents

Important Notice Regarding the Availability of Proxy Materials for the SpecialAnnual Meeting:

The Notice and Proxy Statement and Annual Report are available at www.proxyvote.com.

— — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — —

V27398-P01728        

Oaktree Specialty Lending Corporation

ANNUAL MEETING OF STOCKHOLDERS

March 4, 2024, at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time)

This proxy is solicited by the Board of Directors

The undersigned hereby appoints Armen Panossian, Mathew Pendo and Mary Gallegly, and each of them, and each with full power of substitution, to act as attorneys and proxies for the undersigned to vote all the shares of common stock of Oaktree Specialty Lending Corporation (the “Company”) which the undersigned is entitled to vote at the 2024 Annual Meeting of

Stockholders of the Company, to Be Heldbe held virtually on March 4, 2024.2024, at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time), at the following website: www.virtualshareholdermeeting.com/ocsl2024, and any adjournments or postponements thereof, as indicated on this proxy. The undersigned acknowledges receipt of the Notice of Annual Meeting of Stockholders of the Company.

THIS PROXY IS REVOCABLE AND WILL BE VOTED AS DIRECTED BY THE UNDERSIGNED ON THE REVERSE SIDE. WHERE NO CHOICE IS SPECIFIED, VOTES ENTITLED TO BE CAST BY THE UNDERSIGNED WILL BE CAST FOR EACH OF THE NOMINEES LISTED IN PROPOSAL 1 AND FOR PROPOSAL 2, AS DESCRIBED IN THE PROXY STATEMENT. THE VOTES ENTITLED TO BE CAST BY THE UNDERSIGNED WILL BE CAST IN THE DISCRETION OF THE PROXY HOLDER ON ANY OTHER MATTER THAT MAY PROPERLY COME BEFORE THE MEETING.

Continued and to be signed on reverse side

The accompanying proxy statement is also available at www.proxyvote.com.
V27362-S77915        
Oaktree Specialty Lending Corporation
SPECIAL MEETING OF STOCKHOLDERS
March 4, 2024 10:30 a.m. Pacific Time (1:30 p.m. Eastern Time)
This proxy is solicited by the Board of Directors
The undersigned hereby appoints Armen Panossian, Mathew Pendo and Mary Gallegly, and each of them, and each with full power of substitution, to act as attorneys and proxies for the undersigned to vote all the shares of common stock of Oaktree Specialty Lending Corporation (the “Company”) which the undersigned is entitled to vote at the 2024 Special Meeting of Stockholders of the Company, to be held virtually on March 4, 2024, at 10:30 a.m. Pacific Time (1:30 p.m. Eastern Time), at the following website:
www.virtualshareholdermeeting.com/ocsl2024sm
, and any adjournments or postponements thereof, as indicated on this proxy. The undersigned acknowledges receipt of the Notice of Special Meeting of Stockholders of the Company.
THIS PROXY IS REVOCABLE AND WILL BE VOTED AS DIRECTED BY THE UNDERSIGNED ON THE REVERSE SIDE. WHERE NO CHOICE IS SPECIFIED, VOTES ENTITLED TO BE CAST BY THE UNDERSIGNED WILL BE CAST FOR PROPOSAL 1, AS DESCRIBED IN THE PROXY STATEMENT. THE VOTES ENTITLED TO BE CAST BY THE UNDERSIGNED WILL BE CAST IN THE DISCRETION OF THE PROXY HOLDER ON ANY OTHER MATTER THAT MAY PROPERLY COME BEFORE THE MEETING.
Continued and to be signed on reverse side